<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7582973</article-id><article-id pub-id-type="doi">10.3390/ijms21197078</article-id><article-id pub-id-type="publisher-id">ijms-21-07078</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Monoterpenes and Their Derivatives&#x02014;Recent Development in Biological and Medical Applications</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7439-897X</contrib-id><name><surname>Zieli&#x00144;ska-B&#x00142;ajet</surname><given-names>Mariola</given-names></name><xref rid="c1-ijms-21-07078" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2883-8556</contrib-id><name><surname>Feder-Kubis</surname><given-names>Joanna</given-names></name><xref rid="c1-ijms-21-07078" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-21-07078">Faculty of Chemistry, Wroc&#x00142;aw University of Science and Technology, Wybrze&#x0017c;e Wyspia&#x00144;skiego 27, 50-370 Wroc&#x00142;aw, Poland</aff><author-notes><corresp id="c1-ijms-21-07078"><label>*</label>Correspondence: <email>mariola.zielinska-blajet@pwr.edu.pl</email> (M.Z.-B.); <email>joanna.feder-kubis@pwr.edu.pl</email> (J.F.-K.); Tel.: +48-71-320-2975 (J.F.-K.); Fax: +48-71-328-0475 (J.F.-K.)</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>21</volume><issue>19</issue><elocation-id>7078</elocation-id><history><date date-type="received"><day>29</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Monoterpenes, comprising hydrocarbons, are the largest class of plant secondary metabolites and are commonly found in essential oils. Monoterpenes and their derivatives are key ingredients in the design and production of new biologically active compounds. This review focuses on selected aliphatic, monocyclic, and bicyclic monoterpenes like geraniol, thymol, myrtenal, pinene, camphor, borneol, and their modified structures. The compounds in question play a pivotal role in biological and medical applications. The review also discusses anti-inflammatory, antimicrobial, anticonvulsant, analgesic, antiviral, anticancer, antituberculosis, and antioxidant biological activities exhibited by monoterpenes and their derivatives. Particular attention is paid to the link between biological activity and the effect of structural modification of monoterpenes and monoterpenoids, as well as the introduction of various functionalized moieties into the molecules in question.</p></abstract><kwd-group><kwd>geraniol</kwd><kwd>thymol</kwd><kwd>myrtenal</kwd><kwd>pinene</kwd><kwd>camphor</kwd><kwd>borneol</kwd><kwd>biological activity</kwd><kwd>antiviral activity</kwd><kwd>analgesic activity</kwd><kwd>anti-inflammatory activity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-21-07078"><title>1. Introduction</title><p>Plants have been used for medical purposes for centuries. As such, they have been studied scientifically and traded commercially. Monoterpenes belong to a large and diverse group of naturally occurring compounds. The basic structure of monoterpenes, or monoterpenoids, consists of two linked isoprene units; some of the representative compounds are given in <xref ref-type="fig" rid="ijms-21-07078-f001">Figure 1</xref>. They might be cyclized and oxidized in a variety of ways. Due to the low molecular weight, many of them exist in the form of essential oils. The numbers of monoterpenes have antimicrobial, anti-inflammatory, antioxidant, antipruritic, hypotensive, and analgesic pharmacological properties.</p><p>Functionalization of natural compounds exhibiting native biological activity is one of the most efficient approaches for the synthesis of biologically active substances in medicinal chemistry. This explains, inter alia, why the studies of terpenes and their derivatives are interesting and relevant. Consequently, there is growing body of literature regarding new modifications to these fascinating natural compounds and the corresponding biological and medical applications. Despite the importance of this class of compounds, there are limited reviews on the biological and pharmacological properties of monoterpene derivatives [<xref rid="B1-ijms-21-07078" ref-type="bibr">1</xref>,<xref rid="B2-ijms-21-07078" ref-type="bibr">2</xref>,<xref rid="B3-ijms-21-07078" ref-type="bibr">3</xref>,<xref rid="B4-ijms-21-07078" ref-type="bibr">4</xref>,<xref rid="B5-ijms-21-07078" ref-type="bibr">5</xref>,<xref rid="B6-ijms-21-07078" ref-type="bibr">6</xref>]. Hence, we considered it appropriate to provide a review of selected monoterpene derivatives and their diverse therapeutic activities. We pay particular attention to the structural changes in monoterpenes and the introduction of special groups that increase the biological activity of the studied derivatives. We focus on structural modifications of geraniol (representative of acyclic monoterpenes), thymol (representative of monoterpene monocycles), myrtenal, pinene, camphor, and borneol (representatives of monoterpene bicycles); see <xref ref-type="fig" rid="ijms-21-07078-f002">Figure 2</xref> for an overview. We present those monoterpene derivatives that exhibit several important biological properties; they are often multi-functional or exhibit interesting biological selectivity in their activity.</p></sec><sec><title>2. Acyclic Monoterpene Derivatives</title><sec><title>Geraniol</title><p>Geraniol, <italic>trans</italic>-3,7-dimethyl-2,6-oktadien-1-ol, is a primary, acyclic, doubly unsaturated terpene alcohol with a characteristic flowery, rose-like odor. This monoterpene is extracted from the essential oils of several aromatic plants including <italic>Cinnamomum tenuipilum</italic> Kosterm., <italic>Valeriana officinalis</italic> subsp. <italic>collina</italic> (Wallr.) Nyman, <italic>Phyla scaberrima</italic> (Juss. ex Pers.) Moldenke, and others [<xref rid="B7-ijms-21-07078" ref-type="bibr">7</xref>]. The limited production of geraniol via plant extraction cannot satisfy a great demand from the flavor, fragrance, and other industries, which can only be met by the production utilizing biotechnological processes. Geraniol possesses numerous beneficial medicinal properties, including antioxidant, anti-inflammatory, antimicrobial, antitumor, hepatoprotective, cardioprotective, and neuroprotective [<xref rid="B8-ijms-21-07078" ref-type="bibr">8</xref>,<xref rid="B9-ijms-21-07078" ref-type="bibr">9</xref>].</p><p>A series of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates containing higher or natural alcohol moieties in their structures were designed and synthesized in response to the need for effective and selective inhibitors of carboxylesterase (CES) [<xref rid="B10-ijms-21-07078" ref-type="bibr">10</xref>]. The ester derivative of naturally occurring geraniol is one of them and it proved to be a highly active and selective inhibitor of hCES2, blocking the enzyme within the nanomolar range (IC<sub>50</sub> to ca. 5 nM). Geranyl (2<italic>Z</italic>)-4,4,4-trifluoro-2-[2-(4-methylphenyl) hydrazinylidene]-3-oxobutanoate <bold>1</bold> (<xref ref-type="fig" rid="ijms-21-07078-f003">Figure 3</xref>) show radical-scavenging properties and low acute toxicity, which is why the tested ester derivative of geraniol <bold>1</bold> has a great potential as a biomedicinal inhibitor.</p><p>Geranyl cinnamate ester <bold>2</bold> (<xref ref-type="fig" rid="ijms-21-07078-f003">Figure 3</xref>), tested on <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli,</italic> exhibited excellent antimicrobial (Gram-positive and Gram-negative bacteria) activity, which might be useful in biotechnology. The inhibition zone for <bold>2</bold> demonstrated the synergic effects of two combined natural substrates: geraniol and cinnamic acid.</p><p>Chavez et al. [<xref rid="B11-ijms-21-07078" ref-type="bibr">11</xref>] showed interesting results regarding biologically active geraniol derivatives. A large series of geranylated phenol/methoxyphenol compounds were synthesized to test them in vitro as inhibitor agents of mycelial growth of <italic>Phytophthora cinnamomi</italic>. It turned out that geranylated derivatives containing two hydroxyl groups attached to the aromatic ring, or one of them exchanged by a methoxy group, are the most efficient inhibitors. Some selected structures from the set studied by Chavez et al. are shown in <xref ref-type="fig" rid="ijms-21-07078-f004">Figure 4</xref> (compounds <bold>3&#x02013;8</bold>). Importantly, the activity of those derivatives is as effective as that of Metalaxil<sup>&#x000ae;</sup>, a commonly known commercial fungicide, used as an inhibitor of mycelial growth of <italic>P. cinnamomi</italic>. Some of the discussed compounds are also active against <italic>Botrytis cinerea</italic>, which makes them possibly useful for biotechnological purposes since they may control the infection with more than one pathogen.</p><p><italic>Cis</italic>- and <italic>trans</italic>-geraniol as raw material was used for the synthesis of four isomers of 6,7-dihydroxy-3,7-dimethyloct-2-enoic acid <bold>9&#x02013;12</bold> (<xref ref-type="fig" rid="ijms-21-07078-f005">Figure 5</xref>) to obtain monoterpene derivatives with antifungal activity. The in vivo bioassay results showed that chiral acid (<italic>Z</italic>,<italic>S</italic>)&#x02014;<bold>10</bold> demonstrated promising results as an antifungal agent. The tests confirmed 80&#x02013;100% inhibitory rates of (<italic>Z</italic>,<italic>S</italic>)-6,7-dihydroxy-3,7-dimethyloct-2-enoic acid against <italic>Pseudoperonospora cubensis</italic>, <italic>Erysiphe graminis</italic>, <italic>Puccinia sorghi,</italic> and <italic>Colletotrichum gloeosporioides</italic> at a concentration of 400 &#x000b5;M.</p><p>Biofouling that occurs on the surface of submerged objects, which causes technical and economic problems mainly in the marine industry, but also in many biotechnological processes, is a stimulus to the design and synthesis of effective, safe, and at the same time environmentally benign antifouling compounds. Motivated by these challenges Takamura&#x02019;s research group designed and synthesized a hybrid of molecules containing geraniol and butanolide moieties [<xref rid="B12-ijms-21-07078" ref-type="bibr">12</xref>]. A set of prepared geraniol derivatives consists of eight various molecules <bold>13</bold>, some representatives of this series (<bold>14&#x02013;17</bold>) are included in <xref ref-type="fig" rid="ijms-21-07078-f006">Figure 6</xref>. Biological evaluation of presented geraniol-butanolide hybrid compounds <bold>13</bold> proved that those molecules exhibit antifouling activity against the cypris larvae of the barnacle <italic>Balanus amphitrite</italic> (Darwin, 1854), having the values of EC<sub>50</sub> within the range of 0.30&#x02013;1.31 &#x003bc;M. Since most of those compounds, <bold>13</bold> show low or no toxicity geraniol derivatives might be successfully applied as antifouling agents.</p></sec></sec><sec id="sec3-ijms-21-07078"><title>3. Monoterpene Monocyclic Derivatives</title><sec><title>Thymol</title><p>Thymol (2-isopropyl-5-methylphenol) is a natural phenolic monoterpenoid extracted primarily from <italic>Thymus</italic> species (<italic>Trachyspermum ammi</italic> (L.) Sprague) and other plant sources such as <italic>Baccharis Grisebachii</italic> Hieron. and <italic>Centipeda minima</italic> (L.) A. Br. &#x00026; Asch. and widely used in pharmaceutical and food preservative applications. It is also obtained by various methods at industrial scale from <italic>m</italic>-cresol, or <italic>p</italic>-cymene and piperitone [<xref rid="B13-ijms-21-07078" ref-type="bibr">13</xref>,<xref rid="B14-ijms-21-07078" ref-type="bibr">14</xref>,<xref rid="B15-ijms-21-07078" ref-type="bibr">15</xref>]. Thymol, a component of naturally occurring essential oils, exhibits multiple biological activities [<xref rid="B5-ijms-21-07078" ref-type="bibr">5</xref>,<xref rid="B6-ijms-21-07078" ref-type="bibr">6</xref>]. It is antimicrobial [<xref rid="B16-ijms-21-07078" ref-type="bibr">16</xref>,<xref rid="B17-ijms-21-07078" ref-type="bibr">17</xref>,<xref rid="B18-ijms-21-07078" ref-type="bibr">18</xref>,<xref rid="B19-ijms-21-07078" ref-type="bibr">19</xref>] and anti-inflammatory activity [<xref rid="B20-ijms-21-07078" ref-type="bibr">20</xref>,<xref rid="B21-ijms-21-07078" ref-type="bibr">21</xref>], which means that it is suitable to heal wounds [<xref rid="B22-ijms-21-07078" ref-type="bibr">22</xref>], antioxidative [<xref rid="B23-ijms-21-07078" ref-type="bibr">23</xref>,<xref rid="B24-ijms-21-07078" ref-type="bibr">24</xref>], anticancer activity against human gastric cancer cells [<xref rid="B25-ijms-21-07078" ref-type="bibr">25</xref>]. With its minimal potential toxicity, it shows a promise as a novel botanical pesticide [<xref rid="B26-ijms-21-07078" ref-type="bibr">26</xref>].</p><p>The derivatives with the thymol-based scaffolds have gained much attention owing to their antibacterial, antifungal, anti-inflammatory, anticancer, antitumor, anti-HIV, antiviral, antipyretic, anticonvulsant, and antidepressant properties.</p><p>Zhao et al. isolated different thymol derivatives <bold>18</bold>&#x02013;<bold>22</bold> from <italic>Inula hupehensis</italic> (Ling) Ling and tested them for their activity against the <italic>Staphylococcus aureus</italic>, <italic>Methicillin</italic>-resistant <italic>S. aureus</italic>, and <italic>Escherichia coli</italic>. It was found by the authors that 8-hydroxy-9,10-diisobutyloxy thymol <bold>20</bold> is the most active at MIC values 62.3, 62.8, and 250 &#x003bc;M and it shows inhibitory activities against <italic>Rhizoctonia solani</italic>, <italic>Phytophthora melonis,</italic> and <italic>Peronophythora litchi</italic> with EC<sub>50</sub> of 157, 180, and 141 &#x003bc;M (<xref ref-type="fig" rid="ijms-21-07078-f007">Figure 7</xref>) [<xref rid="B27-ijms-21-07078" ref-type="bibr">27</xref>].</p><p>Mathela and co-workers determined the antibacterial activity of thymol and thymol-derived esters <bold>23</bold> against Gram-positive <italic>Streptococcus mutans</italic>, <italic>S. aureus</italic>, <italic>Bacillus subtilis</italic>, <italic>S. epidermidis</italic>, and one Gram-negative <italic>E. coli</italic> [<xref rid="B28-ijms-21-07078" ref-type="bibr">28</xref>]. Thymol ester derivatives show the most enhanced activity against Gram-positives. 2-Isopropyl-5-methylphenyl acetate <bold>23a</bold> and 2-isopropyl-5-methylphenyl isobutyrate <bold>23c</bold> were found to be more effective than thymol and all other esters against <italic>S. mutans</italic> (MIC = 11.7 and 93.7 &#x003bc;M), <italic>B. subtilis</italic> (MIC = 11.7 and 46.8 &#x003bc;M), and <italic>S. epidermidis</italic> (MIC = 11.7 and 46.8 &#x003bc;M), whereas 2-isopropyl-5-methylphenyl propionate <bold>23b</bold> was found to be more active than thymol only against <italic>B. subtilis</italic> (MIC = 46.8 &#x003bc;M) and <italic>S. epidermidis</italic> (MIC = 46.8 &#x003bc;M) (<xref ref-type="fig" rid="ijms-21-07078-f007">Figure 7</xref>). Another study conducted by Chauhan et al. determined the antifungal effectiveness of thymol ester derivatives against the common soilborne plant pathogenic fungus <italic>R. solani</italic>. Thymol acetate <bold>23a</bold> was found to be a highly effective plant-based fungicide [<xref rid="B29-ijms-21-07078" ref-type="bibr">29</xref>].</p><p>Nagle et al. synthesized thymol derivatives containing pyridine moieties <bold>24</bold> and assessed their antioxidant and antimicrobial properties. The 2-pyridone derivatives exhibit good antifungal activity and a better bacterial inhibition against <italic>E. coli</italic> and <italic>S. aureus</italic> species than thymol. All derivatives are also better antioxidants than the parent compound [<xref rid="B30-ijms-21-07078" ref-type="bibr">30</xref>]. Thymol-<italic>&#x003b2;</italic>-D-glucopyranoside <bold>25</bold> exhibits anticampylobacter activity (<xref ref-type="fig" rid="ijms-21-07078-f008">Figure 8</xref>) [<xref rid="B31-ijms-21-07078" ref-type="bibr">31</xref>].</p><p>Tan and co-worker isolated two new thymol derivatives, 7,9-diisobutyryloxy-8-ethoxythymol <bold>26</bold> and 7-acetoxy-8-methoxy-9-isobutyryloxythymol <bold>27</bold>, from fresh <italic>Ageratina adenophora</italic> (Spreng.) R.M.King &#x00026; H.Rob. roots and tested them for their in vitro antibacterial activity toward three Gram-positive and two Gram-negative bacterial strains. Thymol derivatives <bold>26</bold> and <bold>27</bold> show in vitro bacteriostatic activity toward three Gram-positive bacteria strains (<xref ref-type="fig" rid="ijms-21-07078-f008">Figure 8</xref>) [<xref rid="B32-ijms-21-07078" ref-type="bibr">32</xref>].</p><p>Liu&#x02019;s group isolated a monoterpenoid, 7-acetyl-8,9-dihydroxy thymol <bold>28</bold> together with 7,8-dihydroxy-9-butyryl thymol <bold>29</bold> (<xref ref-type="fig" rid="ijms-21-07078-f008">Figure 8</xref>) from dried flower buds of <italic>Lonicera japonica</italic> Thunb. Both derivatives exhibit significant antibacterial impact on <italic>S. aureus</italic>, <italic>E. coli</italic>, <italic>M. luteus</italic>, and <italic>B. cereus</italic> with IC<sub>50</sub> values ranging from 27.64 to 128.58 &#x003bc;M [<xref rid="B33-ijms-21-07078" ref-type="bibr">33</xref>].</p><p>Other research teams synthesized metronidazole ester <bold>30</bold> and ether <bold>31</bold> with thymol and investigated their in vitro antibacterial activity on <italic>Helicobacter pylori</italic> (the ATCC 26695 and P12) and <italic>Clostridium</italic> (<italic>C. perfringens</italic>) strains. Both compounds demonstrated good activity against <italic>H. pylori</italic> strain. It is worth noting that the ether derivative (<bold>31</bold>) is more active than the ester (<xref ref-type="fig" rid="ijms-21-07078-f008">Figure 8</xref>) [<xref rid="B34-ijms-21-07078" ref-type="bibr">34</xref>].</p><p>El-Miligy et al. focused their attention on the preparation of various thymol hybrid molecules with dual antimicrobial and insecticidal activities free of the irritation side effect from the blocked phenolic hydroxyl group. The targeted compounds were designed to link the biologically active thymol scaffold with different five-membered heterocyclic moieties like 1,3,4-oxadiazole, 1,3,4-thiadiazole, 1,2,4-triazole, thiazole, and 4-thiazolidinone through different spacers. All newly synthesized compounds were evaluated in vitro for their antibacterial activity against <italic>B. subtilis</italic>, <italic>S. aureus</italic>, <italic>E. coli,</italic> and <italic>P. aeruginosa</italic> and tested for their in vitro antifungal activity against <italic>C. albicans</italic>. Only 2-[2-(4-chloro-2-isopropyl-5-methylphenoxy)acetyl]-<italic>N</italic>-phenylhydrazine-1-carbothioamide <bold>32</bold> turned out to have dual antimicrobial activity against <italic>S. aureus</italic>, <italic>B. subtilis</italic> and insecticidal activity against <italic>Tribolium castaneum</italic> (<italic>Herbst</italic>) and <italic>Sitophilus oryzae</italic> (L.) (<xref ref-type="fig" rid="ijms-21-07078-f008">Figure 8</xref>) [<xref rid="B35-ijms-21-07078" ref-type="bibr">35</xref>].</p><p>Swain et al. [<xref rid="B36-ijms-21-07078" ref-type="bibr">36</xref>] synthesized 12 substituted aryl-azo-thymol derivatives. Antimicrobial activities were evaluated by agar-well diffusion against isolated MRSA, ESBL-producing pathogenic bacteria (<italic>S. aureus</italic>, <italic>E. coli</italic>, <italic>K. pneumoniae</italic>, <italic>P. aeruginosa</italic>), and antifungal resistant fungi (<italic>A. fumigatus</italic>, <italic>C. albicans</italic>), in vitro. Among all derivatives, compounds <bold>33&#x02013;35</bold> (<xref ref-type="fig" rid="ijms-21-07078-f009">Figure 9</xref>) have significant antibacterial and antifungal activities with MICs ranging from 40 to 80 &#x003bc;M. The docking scores of derivatives were &#x02212;8.27 to &#x02212;11.44 kcal/mol, against four bacterial targets and &#x02212;9.45 to &#x02212;12.49 kcal/mol against two fungal targets. Thus, as demonstrated by in vitro and silico studies, thymol derivatives are efficient in control over MRSA, ESBL-producing bacteria. A study conducted by Kaur et al. suggested that the compound 4,4&#x02032;-((sulfonylbis(4,1-phenylene))bis(diazene-2,1-diyl))bis(2-isopropyl-5-methylphenol) <bold>36</bold> shows moderate antifungal activity against <italic>A. niger</italic>, <italic>T. rubrum</italic> and <italic>C. glabrata</italic> (<xref ref-type="fig" rid="ijms-21-07078-f009">Figure 9</xref>) [<xref rid="B37-ijms-21-07078" ref-type="bibr">37</xref>].</p><p>Nishida and co-workers synthesized thymol derivatives <bold>37</bold>&#x02013;<bold>40</bold> for antifungal potency against <italic>Aspergillus niger</italic>, <italic>Aspergillus oryzae</italic>, <italic>Fusarium oxysporum</italic>, and <italic>Alternaria alternate</italic>. The antitumor tests showed that 2-isopropyl-5-methylphenyl 5-phenylfuran-2-carboxylate <bold>37</bold> exhibits promising activity against Bel-7402 and KB. Dithymyl ethylene ether thymol derivative <bold>39</bold> shows the highest antifungal activity against <italic>A. niger</italic> (<xref ref-type="fig" rid="ijms-21-07078-f010">Figure 10</xref>) [<xref rid="B38-ijms-21-07078" ref-type="bibr">38</xref>].</p><p>Wang et al. designed and synthesized thymol esters with different heterocyclic units <bold>41</bold> (<xref ref-type="fig" rid="ijms-21-07078-f010">Figure 10</xref>) and tested them for their in vitro antifungal activity against five plant pathogenic fungi (<italic>Alternaria solani</italic>, <italic>Botrytis cinerea</italic>, <italic>Fusarium oxysporum</italic>, <italic>Pyricularia oryzae</italic>, and <italic>Rhizoctonia solani</italic>) by the mycelium growth rate method. Some synthetic esters show good to excellent antifungal activity, especially with furan, thiophene, and pyridine unit. The presence of a bromine atom on the <italic>para</italic> position of benzene moiety increased the antifungal activity [<xref rid="B39-ijms-21-07078" ref-type="bibr">39</xref>].</p><p>The antioxidant activity of thymol is attributed to its phenolic structure and its redox properties, which play an essential role in the adsorbing and neutralizing of free radicals or decomposing peroxides. A wide range of thymol derivatives was explored for structure-radical scavenging activity. By comparing the structural properties of thymol derivatives, their antioxidant activity was explained by the formation of an intramolecular hydrogen bond. Three thymol derivatives, 8,10-dihydroxy-9-isobutyryloxythymol <bold>42</bold>, 8-methoxy-9-hydroxythymol <bold>43</bold>, and 8,9-dehydro-10-hydroxythymol <bold>44</bold>, were isolated from Zataria multiflora extract. The antioxidant activity of these compounds was evaluated with the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Compound <bold>44</bold> has higher antioxidant potential with IC<sub>50</sub> value of 62.5 &#x003bc;M and BDE = 79.2 kcal/mol. These results show that the presence of an unsaturated double bond is the main factor that determines the antioxidant activity of the investigated compounds (<xref ref-type="fig" rid="ijms-21-07078-f011">Figure 11</xref>) [<xref rid="B40-ijms-21-07078" ref-type="bibr">40</xref>]. </p><p>Nagle et al. [<xref rid="B30-ijms-21-07078" ref-type="bibr">30</xref>] evaluated 1,2-dihydro-6-(4-hydroxy-5-isopropyl-2-methylphenyl)-2-oxo-4-arylpyridine-3-carbonitriles for their in vitro antioxidant and antimicrobial activity. Compounds <bold>45</bold> shows much better antioxidant activity than other derivatives (<xref ref-type="fig" rid="ijms-21-07078-f011">Figure 11</xref>).</p><p>Recently, Ashraf&#x02019;s group has studied the substituted benzoic acid and cinnamic acid thymol moieties. They observed that 2-[5-methyl-2-propan-2-yl)phenoxy]-2-oxoethyl-3,4-dihydroxybenzoate <bold>46</bold> has a higher antioxidant potential (IC<sub>50</sub> = 11.30 &#x003bc;M) in comparison to standard ascorbic acid (IC<sub>50</sub> = 24.20 &#x003bc;M) (<xref ref-type="fig" rid="ijms-21-07078-f011">Figure 11</xref>) [<xref rid="B41-ijms-21-07078" ref-type="bibr">41</xref>].</p><p>Bendre and co-worker synthesized a series of thymol-based benzamides <bold>47</bold> (<xref ref-type="fig" rid="ijms-21-07078-f011">Figure 11</xref>), structurally similar to paracetamol [<xref rid="B42-ijms-21-07078" ref-type="bibr">42</xref>]. These compounds were subjected to antioxidant testing by DPPH assay. The results revealed that all the synthesized compounds exhibit notable antioxidant activity and also molecular docking studies indicated that they are good inhibitors of heme oxygenase-1.</p><p>A study conducted by Chen and co-workers evaluated the cytotoxic activity of various thymol derivatives isolated from the root of <italic>Eupatorium cannabinum</italic> subsp. <italic>Asiaticum</italic> Kitam. All compounds were tested in vitro against DLD-1, CCRF-CEM, HL-60, and P388D1 cell lines. The best cytotoxicity is exhibited by 9-acetoxy-8,10-epoxythymol 3-<italic>O</italic>-tiglate <bold>48</bold> (IC<sub>50</sub> values of 0.02 &#x000b1; 0.01, 1.02 &#x000b1; 0.07, and 1.36 &#x000b1; 0.12 &#x003bc;M) and 10-acetoxy-9-<italic>O</italic>-angeloyl-8-hydroxythymol <bold>49</bold> (IC<sub>50</sub> values of 1.14 &#x000b1; 0.16 and 2.63 &#x000b1; 0.22, and 7.63 &#x000b1; 0.94 &#x003bc;M) against the first three cell lines (<xref ref-type="fig" rid="ijms-21-07078-f012">Figure 12</xref>) [<xref rid="B43-ijms-21-07078" ref-type="bibr">43</xref>].</p><p>Rajput et al. [<xref rid="B44-ijms-21-07078" ref-type="bibr">44</xref>] synthesized thymol-based hydrazone derivatives <bold>50</bold>&#x02013;<bold>52</bold> by the condensation of thymol with substituted 2-acetohydrazide of carvacrol and thymol. All compounds were screened for their antioxidant activity with DPPH assay and anticancer activity with SRB assay for the pancreas and colon. The molecular docking studies of all the synthesized derivatives were performed on the COX-2 protein enzyme. In the anticancer and antioxidant tests, thymol hydrazones indicate moderate activities. The molecular docking studies demonstrated excellent binding affinity towards the enzyme (<xref ref-type="fig" rid="ijms-21-07078-f012">Figure 12</xref>).</p><p>New thymol derivatives <bold>53</bold> and <bold>54</bold> (<xref ref-type="fig" rid="ijms-21-07078-f012">Figure 12</xref>) were isolated from the roots of <italic>Eupatorium chinense</italic> L. and tested in vitro for their cytotoxic activities against three cancer cell lines CNE 2, Caski, and HGC-27. The considerable cytotoxic effects against the three cancer cell lines of compound <bold>53</bold> were observed with the IC<sub>50</sub> values ranging from 4.2 to 11.9 &#x003bc;M [<xref rid="B45-ijms-21-07078" ref-type="bibr">45</xref>].</p><p>More recently, Shi and co-workers isolated a few thymol derivatives from the overground parts of <italic>Eupatorium fortunei</italic> Turcz. All compounds were screened for their cytotoxic activities against four human cancer cell lines using MTT assay. Compounds 9-<italic>O</italic>-angeloyloxy-8,9-dehydrothymol <bold>55</bold>, 9-(3-methyl-2-butenoyloxy)-8,10-dehydrothymol <bold>56</bold> and 9-<italic>O</italic>-angeloyl-8,10-dehydrothymol <bold>57</bold> (<xref ref-type="fig" rid="ijms-21-07078-f012">Figure 12</xref>) exhibit notable cytotoxicities with IC<sub>50</sub> values 6.24&#x02013;11.96 &#x003bc;M against MCF-7, HeLa, A549, and Hep G-2 cell lines. The preliminary research indicates that the presence of the methyl group at the C-1 position and the substituted group at C-9 in the structure of these thymol derivatives seem to be essential for the inhibition of the proliferation of four cancer cell lines [<xref rid="B46-ijms-21-07078" ref-type="bibr">46</xref>].</p><p>Chen et al. [<xref rid="B47-ijms-21-07078" ref-type="bibr">47</xref>] isolated several new compounds from the aerial part of <italic>Eupatorium cannabinum</italic> subsp. <italic>asiaticum</italic> Kitam. and assessed their antiinflammatory activities. 9-(3-Methylbutanoyl)-8,10-dehydrothymol <bold>58</bold> and eupatobenzofuran <bold>59</bold> exhibit fMLP/CB (formyl-l-methionyl-l-leucyl-l-phenylalanine/cytochalasin B)-induced elastase release with IC<sub>50</sub> values &#x02264; 18.3 &#x003bc;M (<xref ref-type="fig" rid="ijms-21-07078-f013">Figure 13</xref>).</p><p>Various thymol derivatives were isolated from the aerial part of <italic>Inula wissmanniana</italic> Hand.-Mazz. All compounds were tested for their anti-inflammatory activities against LPS-induced NO production in RAW 264.7 macrophages. 8-Hydroxy-7,9-di-isobutyryloxythymol <bold>60</bold> and 7-hydroxy-8,9-bis(isobutyryloxy)thymol <bold>61</bold> show moderate activities, with IC<sub>50</sub> values of 10.8 and 10.1 &#x003bc;M (<xref ref-type="fig" rid="ijms-21-07078-f013">Figure 13</xref>) [<xref rid="B48-ijms-21-07078" ref-type="bibr">48</xref>]. Nesterkina et al. [<xref rid="B49-ijms-21-07078" ref-type="bibr">49</xref>] synthesized glycine ester of mono-terpenoid. Compound 2-isopropyl-5-methylphenyl 2-aminoacetate <bold>62</bold> demonstrates both anti-inflammatory and analgesic activity (<xref ref-type="fig" rid="ijms-21-07078-f013">Figure 13</xref>).</p><p>The aromatic esters of thymol <bold>63</bold> (<xref ref-type="fig" rid="ijms-21-07078-f014">Figure 14</xref>) were obtained, and their inhibition of the enzyme acetylcholinesterase, and larvicidal activity against <italic>Aedes aegypti</italic> was evaluated. The presence of a benzoate group containing electron-withdrawing substituents on the aromatic ring resulted in the inactivation of the compound against the mosquito larvae, while thymol 4-methoxybenzoate <bold>63e</bold> with electron-donating group exhibits much better activity [<xref rid="B50-ijms-21-07078" ref-type="bibr">50</xref>]. </p><p>Kurt et al. [<xref rid="B51-ijms-21-07078" ref-type="bibr">51</xref>] synthesized a series of thymol derivatives with the carbamate moiety and tested their inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Among the thymol derivatives, 2-isopropyl-5-methylphenyl (4-nitrophenyl)carbamate <bold>64</bold> (<xref ref-type="fig" rid="ijms-21-07078-f014">Figure 14</xref>) shows the strongest inhibition against AChE with an IC<sub>50</sub> value of 2.50 &#x003bc;M. Moreover, insignificant cell death and nontoxicity at 0.07&#x02013;10 &#x003bc;M in H4IIE hepatoma cell toxicity assay was found.</p><p>Another group of researchers synthesized novel oxypropanolamines containing thymol structure <bold>65</bold> and <bold>66</bold> and evaluated their inhibitory effects on <italic>&#x003b1;</italic>-glycosidase, cytosolic carbonic anhydrase I and II isoforms (hCA I and II), and acetylcholinesterase enzymes (AChE) (<xref ref-type="fig" rid="ijms-21-07078-f014">Figure 14</xref>). The results demonstrated that all compounds effectively inhibit <italic>&#x003b1;</italic>-glycosidase, hCA I and II, and AChE enzymes (with Ki values in the range of 63.85&#x02013;851.05 &#x003bc;M for <italic>&#x003b1;</italic>-glycosidase, 1.11&#x02013;17.34 &#x003bc;M and 2.97&#x02013;17.83 &#x003bc;M for hCA I and hCA II, respectively, and 13.58&#x02013;31.45 &#x003bc;M for AChE). Furthermore, the authors concluded that derivatives <bold>66a</bold>-<bold>c</bold> exhibited the most significant antibacterial activity on <italic>A. baumannii</italic>, <italic>P. aeruginosa</italic>, <italic>E. coli,</italic> and <italic>S. aureus</italic> strains among all the tested compounds [<xref rid="B52-ijms-21-07078" ref-type="bibr">52</xref>].</p><p>Henry and co-workers synthesized seven new alkyl 4-oxobutanoate derivatives of thymol <bold>67</bold> and screened them for tyrosinase inhibitory activity using mushroom tyrosinase (<xref ref-type="fig" rid="ijms-21-07078-f014">Figure 14</xref>). Generally, the alkyl 4-oxobutanoate derivatives exhibit better inhibitory effects than the ethyl thymol 4-oxobutanoic acids. The data demonstrated the correlations between the structure of the alkyl side chain and tyrosinase inhibitory activity. The best results were obtained for esters containing three or four carbon atoms in the alkyl chain with IC<sub>50</sub> values range from 102.3 to 191.4 &#x003bc;M [<xref rid="B53-ijms-21-07078" ref-type="bibr">53</xref>].</p><p>Haddad et al. isolated thymohydroquinone dimethyl ether (THQ) <bold>68</bold> from the sample of <italic>Anaphalis triplinervis</italic> (Sims) Sims ex C.B.Clarke essential oil (EO) (<xref ref-type="fig" rid="ijms-21-07078-f015">Figure 15</xref>). The authors also investigated the antiviral activity of <italic>Anaphalis triplinervis</italic> (Sims) Sims ex C.B.Clarke EO and its major compound THQ against ZIKV. Virological assays were performed on human lung epithelial A549 cells infected with either GFP reporter ZIKV or epidemic viral strain. To evaluate the acute toxicity of THQ in vivo the zebrafish assay was used. The results demonstrated that both EO and THQ inhibit ZIKV infection in human cells with IC<sub>50</sub> values of 38 and 45 &#x003bc;M. It was noted that the inoculation of THQ at the antiviral effective concentration does not lead to any stress and does not impact fish survival [<xref rid="B54-ijms-21-07078" ref-type="bibr">54</xref>].</p><p>Many studies have demonstrated that serotonin receptors, especially the 5-HT6 subtype, indicate great suitability for the potential therapy of the topic civilization CNS diseases.</p><p>Latacz et al. performed an exploration into the group of 1,3,5-triazine-methylpiperazines and screened them for pro-cognitive action and anxiolytic-like effect in the behavioral in vivo and in vitro tests. The best results were observed for the thymol triazine derivative. Compound 4-((2-isopropyl-5-methylphenoxy)methyl)-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine <bold>69</bold> (<xref ref-type="fig" rid="ijms-21-07078-f015">Figure 15</xref>) shows the most promising pharmacological and drug-likeness profile and seems to be of higher importance due to its structure lacking the indole and sulfone fragments and the best 5-HT6R binding properties [<xref rid="B55-ijms-21-07078" ref-type="bibr">55</xref>].</p></sec></sec><sec id="sec4-ijms-21-07078"><title>4. Monoterpene Bicyclic Derivatives</title><sec id="sec4dot1-ijms-21-07078"><title>4.1. Myrtenal</title><p>Myrtenal is a monoterpene present in many medicinal plants such as cumin, pepper, mint, and eucalyptus. Monoterpenes consist of two isoprene units. They naturally occur in plants and essential oils. They are antioxidant, anticancer, antidiabetic, and act as cyclooxygenase-inhibitors and immunostimulants [<xref rid="B4-ijms-21-07078" ref-type="bibr">4</xref>,<xref rid="B56-ijms-21-07078" ref-type="bibr">56</xref>,<xref rid="B57-ijms-21-07078" ref-type="bibr">57</xref>,<xref rid="B58-ijms-21-07078" ref-type="bibr">58</xref>,<xref rid="B59-ijms-21-07078" ref-type="bibr">59</xref>,<xref rid="B60-ijms-21-07078" ref-type="bibr">60</xref>]. </p><p>1,2,4-Triazole derivatives are antimicrobial, antifungal, antitumor, anti-inflammatory, antituberculosis, and herbicidal properties [<xref rid="B61-ijms-21-07078" ref-type="bibr">61</xref>,<xref rid="B62-ijms-21-07078" ref-type="bibr">62</xref>,<xref rid="B63-ijms-21-07078" ref-type="bibr">63</xref>]. A series of novel myrtenal-based 4-methyl-1,2,4-triazole-thioethers were synthesized by Duan and co-workers and tested as antifungal agents [<xref rid="B64-ijms-21-07078" ref-type="bibr">64</xref>]. Antifungal activities of these compounds were evaluated by the in vitro method against Fusarium wilt on cucumber (<italic>Fusarium oxysporum</italic> f. sp. <italic>cucumerinum</italic>), apple root spot (<italic>Physalospora piricola</italic>), tomato early blight (<italic>Alternaria solani</italic>), speckle on peanut (<italic>Cercospora arachidicola</italic>), and wheat scab (<italic>Gibberella zeae</italic>) at 50 &#x003bc;g/mL. It was found that myrtenal-based compounds <bold>70</bold> such as 4-methyl-1,2,4-triazole-<italic>i</italic>-propylthioether <bold>70b</bold>, 4-methyl-1,2,4-triazole-<italic>o</italic>-nitrobenzylthioether <bold>70c</bold>, and 4-methyl-1,2,4-triazole-ethylthioether <bold>70a</bold> (<xref ref-type="fig" rid="ijms-21-07078-f016">Figure 16</xref>) exhibit excellent antifungal activity against <italic>P. piricola</italic> with inhibition rates of 98.2%, 96.4%, and 90.7%, respectively, showing better or comparable antifungal activity than that of the commercial fungicide azoxystrobin with an inhibition rate of 96.0%, which served as a positive control. Most of the target compounds have more enhanced activities than myrtenal, indicating that the incorporation of 1,2,4-triazole-thioether moiety into the myrtenal molecule was favorable to the increase of antifungal activity.</p><p>Duan&#x02019;s group also focused their attention on the preparation of novel myrtenal-based 2-acyl-1,2,4-triazole-3-thiones [<xref rid="B65-ijms-21-07078" ref-type="bibr">65</xref>]. These compounds were evaluated in vitro for their antifungal and herbicidal activities. Some of those myrtenal derivatives exhibit favorable antifungal activity at 50 mg/L. Myrtenal-derived 2-(<italic>p</italic>-methylbenzoyl)-1,2,4-triazole-3-thione <bold>71a</bold> demonstrates 83.7% and 72.5% inhibition rates against corn southern leaf blight (<italic>Bipolaris maydis</italic>) and apple root spot (<italic>Physalospora piricola</italic>), respectively, and myrtenal-derived 2-(3&#x02032;,5&#x02032;-dimethylbenzoyl)-1,2,4-triazole-3-thione <bold>71b</bold> has a 72.5% inhibition rate against <italic>P. piricola</italic> (the positive control commercial fungicide chlorothalonil with growth inhibition rates of 90.4% and 75.0% against <italic>B. maydis</italic> and <italic>P. piricola</italic>, respectively). Furthermore, most of the derivatives exhibit excellent herbicidal activity against the root-growth of rape (<italic>Brassica campestris</italic>) at 100 mg/L, with inhibition rates of 80.2% to 99.1%, showing much better herbicidal activity than that the commercial herbicide flumioxazin (positive control) with an inhibition rate of 63.0% (<xref ref-type="fig" rid="ijms-21-07078-f016">Figure 16</xref>). </p><p>Adamantane derivatives have been widely used in clinical practice [<xref rid="B66-ijms-21-07078" ref-type="bibr">66</xref>]. The applicability of compounds with both the adamantane and myrtenal moieties was investigated in various biological tests.</p><p>Suslov and co-workers synthesized a few new nitrogen-containing compounds with adamantane and myrtenal framework and studied the anxiolytic activity of the obtained products in male Balb/C mice in the elevated plus-maze (EPM) test. The results of this investigation showed that <italic>N</italic>-{[(1<italic>R</italic>,5<italic>S</italic>)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]-methyl}adamantan-2-amine <bold>72</bold> exhibits tranquilizing activity and pronounces anxiolytic activity in the EPM test (<xref ref-type="fig" rid="ijms-21-07078-f016">Figure 16</xref>) [<xref rid="B67-ijms-21-07078" ref-type="bibr">67</xref>]. Compound <bold>72</bold> was tested in vitro for antiviral activity against the influenza virus A/California/07/09 (H1N1)pdm09. The results indicated that the introduction of a myrtenal fragment led to an increase in the antiviral activity of adamantylamine derivatives against the adamantylamine resistant virus: The selectivity index of the majority of the synthesized amines was higher than that of rimantadine and amantadine [<xref rid="B68-ijms-21-07078" ref-type="bibr">68</xref>]. Compound <bold>73</bold> was synthesized from 1-aminoadamantane and (&#x02013;)-myrtenal and its cytotoxic activity against human cancer cells CEM-13, MT-4, and U-937 was studied. Adamantylamine <bold>73</bold> revealed a high activity against all tumor lines used (CTD<sub>50</sub> = 12&#x02013;21 &#x000b5;M) along with low toxicity for MDCK cells (CTD<sub>50</sub> = 1500 &#x000b5;M). Furthermore, no genotoxic effect on normal cells was observed [<xref rid="B69-ijms-21-07078" ref-type="bibr">69</xref>], whereas myrtenal-derived amine <bold>74</bold> synthesized from 1-aminoadamantane and (+)-myrtenal inhibited anti-Tdp1 activity with IC<sub>50</sub> values of 6.1&#x003bc;M (<xref ref-type="fig" rid="ijms-21-07078-f016">Figure 16</xref>) [<xref rid="B70-ijms-21-07078" ref-type="bibr">70</xref>].</p><p>Adamantane derivatives containing N atoms at the bridging positions manifested analgesic activity in vivo tests. Suslov&#x02019;s group prepared a series of new compounds linking diazaadamantane and monoterpene moieties such as substituted 5,7-dimethyl-1,3-diazaadamantan-6-ones, which were vastly potent analogs of analgesic. The results showed that analgesic activity was completely lost if the 5- and 7-alkyl substituents were lengthened by one or two CH<sub>2</sub> groups in 5,7-dialkyl-1,3-diazaadamantan-6-ones substituted with monoterpenoids in the aminal position <bold>75</bold>. In addition, compound <bold>76a</bold> with a 6-OH instead of the carbonyl group was found to be active in the visceral pain test and it does not show analgesic activity for tactile pain, while the reduction in the ketone to methylene group in diazaadamantane <bold>76b</bold> with (&#x02013;)-myrtenal in the aminal position of the heteroadamantane structure affected the loss of analgesic properties in both tests (<xref ref-type="fig" rid="ijms-21-07078-f016">Figure 16</xref>) [<xref rid="B71-ijms-21-07078" ref-type="bibr">71</xref>].</p><p>Szakonyi and co-workers reported on the synthesis of (&#x02013;)-myrtenal-based 1,2,4- and 1,3,4-oxadiazole derivatives. All prepared compounds along with their amidoxime type intermediates were screened in vitro for their antiproliferative activities against four human malignant cell lines using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. <italic>O</italic>-Acylated amidoxime <bold>77</bold> was found to have highly potent growth inhibitory activities with calculated IC<sub>50</sub> values comparable to those of reference agent cisplatin. However, this molecule exhibited lower antiproliferative activities against the triple-negative breast cancer cell line (MDA-MB-231) than other cell lines used in gynecology. Unfortunately, the other compounds <bold>78</bold>&#x02013;<bold>82</bold> exhibited a visibly weaker action against the ovarian cancer cell line (A2780) (<xref ref-type="fig" rid="ijms-21-07078-f017">Figure 17</xref>) [<xref rid="B72-ijms-21-07078" ref-type="bibr">72</xref>].</p></sec><sec id="sec4dot2-ijms-21-07078"><title>4.2. Pinene</title><p>Pinene (C<sub>10</sub>H<sub>16</sub>) is a bicyclic, double-bond terpenoid hydrocarbon, representing the family of monoterpenes. The <italic>&#x003b1;</italic>-pinene and <italic>&#x003b2;</italic>-pinene are two structural isomers found in nature, e.g., in pine (coniferous trees) essential oils (EO). Both isomers have two enantiomers (+) and (&#x02013;) (<xref ref-type="fig" rid="ijms-21-07078-f018">Figure 18</xref>) and exhibit diverse pharmacological activities, e.g., antimicrobial, antiviral, antispasmodic, antifungal, antiviral, anticancer, antimalarial, antioxidant, and anti-inflammatory effects [<xref rid="B73-ijms-21-07078" ref-type="bibr">73</xref>,<xref rid="B74-ijms-21-07078" ref-type="bibr">74</xref>,<xref rid="B75-ijms-21-07078" ref-type="bibr">75</xref>,<xref rid="B76-ijms-21-07078" ref-type="bibr">76</xref>].</p><p>Song and co-workers focused their attention on the preparation of novel 3-cyanopyridine derivatives of (&#x02013;)-<italic>&#x003b2;</italic>-pinene 83 (<xref ref-type="fig" rid="ijms-21-07078-f019">Figure 19</xref>) [<xref rid="B77-ijms-21-07078" ref-type="bibr">77</xref>]. All compounds were evaluated in vitro against four bacteria (<italic>Klebsiella pneumoniae</italic>, <italic>Enterobacter aerogenes</italic>, <italic>Staphylococcus aureus</italic>, <italic>Staphylococcus epidermidis</italic>) and a fungus (<italic>Candida albicans</italic>). The tested compounds exhibited moderate antibacterial activity against the Gram-positive bacteria <italic>S. aureus</italic>, <italic>S. epidermidis</italic>, weak antibacterial activity against the Gram-negative bacteria <italic>K. pneumoniae</italic>, <italic>E. aerogenes</italic>, and moderate antifungal activity against <italic>C. albicans</italic>. 4-(3,4-Difluorophenyl)-2-hydroxy-7,7-dimethyl-5,6,7,8-tetrahydro-6,8-methanoquinoline-3-carbonitrile <bold>83h</bold> with double fluoro substituents at <italic>m</italic>- and <italic>p</italic>-position on the pyridine ring demonstrates the best antimicrobial activity against overall strains.</p><p>Wang&#x02019;s group synthesized a series of novel hydronopylformamides derivatives <bold>84</bold> from (&#x02013;)-<italic>&#x003b2;</italic>-pinene and evaluated the repellency of these derivatives against the cockroach <italic>Blattella germanica</italic> (<xref ref-type="fig" rid="ijms-21-07078-f019">Figure 19</xref>). The results showed that only the compound with methyl, ethyl, phenyl, and 4-chlorophenyl units exhibited repellency against <italic>B. germanica</italic>. Compound 3-((1<italic>S</italic>,5<italic>S</italic>)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl)-<italic>N</italic>-methylpropanamide <bold>84a</bold> shows a much better repellency than other derivatives and the traditional insect repellent <italic>N</italic>,<italic>N</italic>-diethyl-3-methylbenzamide (DEET) [<xref rid="B78-ijms-21-07078" ref-type="bibr">78</xref>].</p><p>Thio derivatives of pinane series exhibit high antioxidant, antifungal, antiaggregation, anticoagulant, and pronounced antimycotic activity. Nikitina et al. [<xref rid="B79-ijms-21-07078" ref-type="bibr">79</xref>] obtained pinane sulfide <bold>85</bold> by the addition of methyl hydrosulfanylacetate to the double bond of <italic>&#x003b2;</italic>-pinene and investigated this compound for hemocoagulation activity (<xref ref-type="fig" rid="ijms-21-07078-f020">Figure 20</xref>). The results indicated that pinane sulfide <bold>85</bold> (methyl [(1<italic>R</italic>,2<italic>R</italic>,5<italic>R</italic>)-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)-methylthio]ethanoate) inhibits platelet receptor activity. It inhibits completely platelet aggregation induced by adrenaline, ADP, collagen, arachidonic acid, and also reduces the effect of ristomycin. This compound inhibits both platelet and coagulation hemostasis, which allows one to use it for the creation of promising antiaggregation drugs and the stabilization of blood products.</p><p>Ye et al. [<xref rid="B80-ijms-21-07078" ref-type="bibr">80</xref>] designed and synthesized novel <italic>&#x003b1;</italic>-pinene derivatives as a potential antitumor agent. It was found that compound <bold>86</bold> (6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methyl-4-methylbenzenesulfonate) (<xref ref-type="fig" rid="ijms-21-07078-f020">Figure 20</xref>) exhibits the strongest inhibition on hepatoma carcinoma cell BEL-7402. The results showed that <bold>86</bold> demonstrates good antiliver cancer activity with the IC<sub>50</sub> of 84.7 &#x003bc;M in vitro, and inhibits tumor growth in vivo with dose-dependent. The authors suggested that compounds <bold>86</bold>, apart from arresting the growth of hepatoma cells in the S phase, induce apoptosis in hepatoma cells, down-regulate the expression of C-myc, CDK2 and CyclinE, and up-regulate the level of p53.</p><p>Thiosemicarbazones, containing thiourea moiety, show significant biological&#x02014;particularly anticancer&#x02014;activities. Wang and co-workers [<xref rid="B81-ijms-21-07078" ref-type="bibr">81</xref>] designed and synthesized a collection of nopinone-based thiosemicarbazone derivatives <bold>87</bold> as potent antineoplastic agents (<xref ref-type="fig" rid="ijms-21-07078-f020">Figure 20</xref>). Most of those thiosemicarbazones demonstrate considerable cytotoxic activity against three human cancer cell lines (MDA-MB-231, SMMC-7721, and Hela). Among thiosemicarbazone derivatives, the compound with phenyl group substituted at the amino position (R<sub>2</sub> = Ph) and <italic>p</italic>-electron-donating group (R<sub>1</sub> = OMe) exhibits the most potent antiproliferative activity against the tested cancer cell lines with the IC<sub>50</sub> values of 2.79 &#x000b1; 0.38, 2.64 &#x000b1; 0.17 and 3.64 &#x000b1; 0.13 &#x003bc;M, respectively, and low cytotoxicity on human normal embryo lung fibroblasts (Hlf-1).</p><p>Another example presents a library of <italic>&#x003b2;</italic>-pinene-based thiazole derivatives <bold>88</bold> (<xref ref-type="fig" rid="ijms-21-07078-f020">Figure 20</xref>) [<xref rid="B82-ijms-21-07078" ref-type="bibr">82</xref>]. The obtained compounds were evaluated for their antitumor in vitro activities, and the results demonstrated that most target compounds showed potent antiproliferative activities against three human cancer cell lines. Especially, compound 4-(2-(2-(6,6-dimethyl-3-(4-nitrobenzylidene)bicyclo[3.1.1] heptan-2-ylidene)hydrazinyl)thiazol-4-yl)phenol (R<sub>1</sub> = NO<sub>2</sub>, R<sub>2</sub> = OH) displays excellent cytotoxic activity against Hela, CT-26, and SMMC-7721 cell lines with IC<sub>50</sub> values of 3.48, 8.84, and 6.69 &#x003bc;M, respectively. These findings indicated that thiazole with a hydroxyl group attached to the phenyl group is favorable for increasing anticancer activity.</p><p>A series of new chiral <italic>N</italic>-terpenyl benzisoselenazol-3(2<italic>H</italic>)-ones with three monoterpene moieties&#x02014;<italic>p</italic>-menthane, pinane, and carane&#x02014;was synthesized by &#x0015a;cianowski and co-workers [<xref rid="B83-ijms-21-07078" ref-type="bibr">83</xref>]. The compounds were tested as antioxidants and anticancer agents. The best antioxidant activity and the highest antiproliferative potential were observed for <italic>&#x003b1;</italic>- and <italic>&#x003b2;</italic>-pinane <italic>N</italic>-substituted benzisoselenazolones <bold>89</bold> and <bold>90</bold> (<xref ref-type="fig" rid="ijms-21-07078-f020">Figure 20</xref>). The <italic>N</italic>-isopinocampheyl-1,2-benzisoselenazol-3(2<italic>H</italic>)-one <bold>89</bold> is the best peroxide scavenger and antiproliferative agent on the human promyelocytic leukemia cell line HL-60 with IC<sub>50</sub> of 7.1 &#x003bc;M (HL-60 cell line).</p><p>Lin et al. [<xref rid="B84-ijms-21-07078" ref-type="bibr">84</xref>] presented the efficient synthesis of <italic>&#x003b1;</italic>-pinene-based dithiadiazoles <bold>92</bold> by the cyclization reaction of <italic>&#x003b1;</italic>-pinene-based disubstituted phenyl acyl amino thioureas <bold>91</bold>. The experiments showed that both compounds have weak herbicidal activity and the inhibition rates against fungi (<italic>Brassica campestris</italic> L., <italic>Physalospora piricola</italic>) are moderate except for 2,2&#x02032;-methyl-substituted derivatives. A better plant growth-regulating activity was observed for derivatives with halo groups as compared to the other functional groups (<xref ref-type="fig" rid="ijms-21-07078-f021">Figure 21</xref>).</p></sec><sec id="sec4dot3-ijms-21-07078"><title>4.3. Camphor</title><p>Camphor, 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one, is an abundant monoterpenoid with a bicyclic framework structure. This inexpensive natural compound occurs in dextrorotatory form, i.e., <italic>R</italic>,<italic>R</italic>-(+)-camphor, and was one of the first plant metabolites isolated in the chemically pure form [<xref rid="B85-ijms-21-07078" ref-type="bibr">85</xref>]. Nowadays, it is obtained through distillation of camphor laurel tree wood (<italic>Cinnamomum camphora</italic> (L.) J.Presl) or otherwise by chemical transformation of other natural products, among other turpentines [<xref rid="B86-ijms-21-07078" ref-type="bibr">86</xref>]. The laevorotatory form (<italic>S</italic>,<italic>S</italic>-camphor) only exists in a synthetic form or very small quantities in specific species of plants [<xref rid="B87-ijms-21-07078" ref-type="bibr">87</xref>]. Camphor has been used widely as a fragrance in cosmetics and perfumes, a food flavorant, and in household cleaners [<xref rid="B86-ijms-21-07078" ref-type="bibr">86</xref>]. This bicyclic compound possesses many biological activities: Insecticidal, analgesic, antimicrobial, antiviral, anticoccidial, antinociceptive, anticancer, and antitussive [<xref rid="B86-ijms-21-07078" ref-type="bibr">86</xref>,<xref rid="B88-ijms-21-07078" ref-type="bibr">88</xref>]. Importantly, (+)-camphor is one of the most commercially important aroma chemicals with an annual market value of US$80&#x02013;100 million [<xref rid="B89-ijms-21-07078" ref-type="bibr">89</xref>].</p><p>Imines based on natural (+)-camphor proved to be a promising source of antimicrobial and antiviral agents [<xref rid="B90-ijms-21-07078" ref-type="bibr">90</xref>]. Yarovaya et al. showed the designing strategy of (+)-camphor derivatives with the imine group (<xref ref-type="fig" rid="ijms-21-07078-f022">Figure 22</xref>) was prepared based on significant structural data described by the authors and shows the elements of the molecule which affects biological activity [<xref rid="B91-ijms-21-07078" ref-type="bibr">91</xref>].</p><p>The most common (+)-camphor-based imine is camphecene <bold>93</bold> (<xref ref-type="fig" rid="ijms-21-07078-f023">Figure 23</xref>), 2-(<italic>E</italic>)-((1<italic>R</italic>,4<italic>R</italic>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene-aminoethanol, which was established as an effective inhibitor of influenza virus H1N1 with a selectivity index (SI) value of 500.3 [<xref rid="B88-ijms-21-07078" ref-type="bibr">88</xref>] together with low toxicity. Camphecene remains promising as a potential antiviral due to the low pathogenicity of resistant viruses that may arise [<xref rid="B92-ijms-21-07078" ref-type="bibr">92</xref>].</p><p>An interesting series of works on the topic of (+)-camphor-based imine derivatives is presented by Sokolova et al. [<xref rid="B88-ijms-21-07078" ref-type="bibr">88</xref>,<xref rid="B93-ijms-21-07078" ref-type="bibr">93</xref>,<xref rid="B94-ijms-21-07078" ref-type="bibr">94</xref>]. The authors pointed up a very efficient antiviral activity of synthesized monoterpene derivatives. In their 2017 work [<xref rid="B94-ijms-21-07078" ref-type="bibr">94</xref>], designed compounds were prepared from commercially available natural (+)-camphor and various amines (<xref ref-type="fig" rid="ijms-21-07078-f024">Figure 24</xref>), whereas the procedures for the monoterpene derivatives were simple and reproducible. The prepared compounds were tested in vitro for antiviral activity. Most of those (+)-camphor-based imine derivatives&#x02014;especially <bold>94</bold> and <bold>95</bold>&#x02014;were capable of inhibiting the drug-resistant strains of influenza A virus subtypes A/Puerto Rico/8/34 and A/California/07/09 of H1N1pdm09. Analysis of the structure&#x02013;activity relationship showed that the virus-inhibiting properties are strongly dependent on the length of an imine-conjugated moiety: Compounds with a shorter chain display higher activity, whereas the suppressing action of those aliphatic (+)-camphor imines with long aliphatic chains is lower.</p><p>Other (+)-camphor derivatives, having two bicyclic monoterpene elements, two imine groups, and additionally two quaternary atoms in their structures connected with various lengths of the alkyl chain (<xref ref-type="fig" rid="ijms-21-07078-f025">Figure 25</xref>), were synthesized and tested through their biological applications [<xref rid="B93-ijms-21-07078" ref-type="bibr">93</xref>]. Compounds with the pentyl <bold>97</bold> and nonyl <bold>98</bold> aliphatic chains are very efficient in inhibiting the influenza virus A(H1N1)pdm09 reproduction. Bis-quaternary ammonium bromide with a dodecyl alkyl chain <bold>99</bold> has the highest activity for the CEM-13 cells. The results suggest that tested dimeric bis-quaternary ammonium salts <bold>97</bold>&#x02013;<bold>99</bold> might be used as components of drugs for suppressing malignant tumor development.</p><p>The next example, showing the use of naturally occurring camphor as a substrate, led to obtaining imines <bold>100</bold>&#x02013;<bold>102</bold>, and also hydrazones <bold>103</bold>&#x02013;<bold>105</bold>, which belong to <italic>R</italic>,<italic>R</italic>-(+)-camphor derivatives [<xref rid="B95-ijms-21-07078" ref-type="bibr">95</xref>]. <xref ref-type="fig" rid="ijms-21-07078-f026">Figure 26</xref> presents a few selected examples from a large set of synthesized compounds. Antimycobacterial activity against <italic>Mycobacterium tuberculosis</italic> ATCC 27294 was investigated for all the obtained (+)-camphor derivatives and the results were satisfactory. (<italic>E</italic>)-2-Hydroxy-<italic>N</italic>-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene)aniline <bold>100</bold>, one of the imine derivatives, exhibits the best activity (minimal inhibitory concentration MIC = 3.12 &#x000b5;M). The antimycobacterial activity against <italic>M. tuberculosis</italic> of this (+)-camphor derivative is comparable to that of the antitubercular drug ethambutol. The other derivatives exhibit modest antimycobacterial activities at a range of 25&#x02013;50 &#x000b5;M. In vitro tests against cancer cell lines show noncytotoxic activities for all the (+)-camphor derivatives.</p><p>Another example presents a series of <italic>N</italic>-acylhydrazones containing a monoterpene fragment and different aliphatic, aromatic, and heterocyclic pharmacophore scaffolds (<xref ref-type="fig" rid="ijms-21-07078-f027">Figure 27</xref>) [<xref rid="B96-ijms-21-07078" ref-type="bibr">96</xref>]. (+)-Camphor-based <italic>N</italic>-acylhydrazones exhibit inhibitory activity against vaccinia and influenza viruses. Compounds <bold>108</bold>, <bold>109</bold>, and <bold>111</bold>, containing an aromatic substituent, demonstrate low toxicity and the best activity against vaccinia virus. Furthermore, compound <bold>111</bold>, having aromatic and heterocyclic moieties, as the only one among the tested series of compounds, shows moderate activity against the influenza virus.</p><p>Sokolova et al. [<xref rid="B97-ijms-21-07078" ref-type="bibr">97</xref>] presented the efficient synthesis of <italic>&#x003b1;</italic>-truxillic acid derivatives containing a monoterpenoid fragment. The authors used natural terpene, (+)-camphor, as a starting monoterpenoid because of its high biological activity and commercial availability. Novel (+)-camphor derivative of <italic>&#x003b1;</italic>-truxillic acid, namely 2,4-diphenyl-<italic>N</italic><sup>1</sup>,<italic>N</italic><sup>3</sup>-bis((1<italic>R</italic>,4<italic>R</italic>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)cyclobutane-1,3-dicarboxamide) <bold>112</bold> (<xref ref-type="fig" rid="ijms-21-07078-f028">Figure 28</xref>), was investigated for its analgesic activity in in vivo tests. The tested compound containing the cyclobutane unit and monoterpene bicyclic element at a dose of 10 mg/kg (per os) has good analgesic activity. Importantly, <italic>&#x003b1;</italic>-truxillic acid (tested for the same dose) did not show analgesic activity. Thus, the cause of considerable analgesic activity occurring in the tested compound is the introduction of (+)-camphor <bold>112</bold> fragment into <italic>&#x003b1;</italic>-truxillic acid.</p><p>Another example of the camphor amide derivatives is presented in <xref ref-type="fig" rid="ijms-21-07078-f029">Figure 29</xref>. Those heterocyclics were tested as potential vaccinia virus (VV) inhibitors [<xref rid="B98-ijms-21-07078" ref-type="bibr">98</xref>]. Bioassay results revealed that synthesized amides with 4-methylpiperidine <bold>113a</bold> and morpholine <bold>114b</bold> fragments show the best inhibitory activity against VV with the IC<sub>50</sub> values of 2.5 and 7.5 &#x000b5;M, respectively, with low cytotoxicity.</p><p>A series of hybrid molecules based on (+)-camphor derivatives and quinolizidine alkaloid (&#x02013;)-cytisine (<xref ref-type="fig" rid="ijms-21-07078-f030">Figure 30</xref>) were presented by Artyushin et. al. [<xref rid="B99-ijms-21-07078" ref-type="bibr">99</xref>] and tested for their cytotoxicity and virus-inhibiting activity. It was proven that the antiviral activity is affected by the length and nature of linkers between cytisine and (+)-camphor moieties. Compound <bold>117d</bold>, which contains the cytisine fragment separated from triazole ring by &#x02013;C<sub>6</sub>H<sub>12</sub>&#x02013; aliphatic linker shows the highest activity with relatively low toxicity (CC<sub>50</sub> = 168 &#x003bc;mol, IC<sub>50</sub> = 8 &#x003bc;mol, SI = 20). Its selectivity index appears higher than that of the commonly known reference compound: Rimantadine.</p><p>(+)-Camphoric acid <bold>120</bold> (<xref ref-type="fig" rid="ijms-21-07078-f031">Figure 31</xref>), which is the product of oxidation of (+)-camphor, was a substrate for an effective technique for the one-stage synthesis of new polycyclic nitrogen-containing compounds [<xref rid="B100-ijms-21-07078" ref-type="bibr">100</xref>]. In this work, various aliphatic and aromatic diamines were selected as reagents for target polycyclic molecules because of the considerable role in the medicinal and organic chemistry of nitrogen-containing heterocyclic compounds. In vitro screening for the activity of the influenza virus A was performed for all synthesized polycyclic nitrogen-containing heterocyclic compounds, and synthetic analogs of natural alkaloids. <xref ref-type="fig" rid="ijms-21-07078-f031">Figure 31</xref> shows selected structures (<bold>121</bold>&#x02013;<bold>124</bold>), which were most effective in inhibiting the influenza virus A (H1N1). Compound <bold>124</bold>, exhibiting the best antivirus agent among others, has inhibitory activity against different strains of influenza virus A. This quinazoline like agent <bold>124</bold> has inhibitory activity against strain H5N2 comparable to reference compounds. In the case of effective inhibiting of strain H1N1, molecule <bold>124</bold> indicates an antivirus activity exceeding that of reference compounds.</p><p>Mikl&#x000e1;&#x00161; et al. presented an interesting set of homochiral quaternary ammonium sulfonamides bearing hydrophobic camphor derived moieties [<xref rid="B101-ijms-21-07078" ref-type="bibr">101</xref>]. The authors used commercially available (1<italic>S</italic>)-(+)-camphor-10-sulfonic acid <bold>125</bold> (<xref ref-type="fig" rid="ijms-21-07078-f032">Figure 32</xref>), as a precursor for targeted monoterpene-based sulphonamides molecules <bold>126</bold>&#x02013;<bold>128</bold> (<xref ref-type="fig" rid="ijms-21-07078-f032">Figure 32</xref>). Optically active quaternary ammonium bromides <bold>126</bold>&#x02013;<bold>128</bold> containing camphor components were tested as antibacterial and antifungal agents and almost all of them show important antimicrobial activities. Compound <italic>N</italic>-{2-[((1<italic>S</italic>, 4<italic>R</italic>)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methylsulfonamido]ethyl}-<italic>N</italic>,<italic>N</italic>-dimethyltetradecan-1-aminium bromide <bold>128</bold> is regarded as highly active against tested bacteria and fungi. The microbiological activity of this bromide <bold>128</bold> is approximately 25 times more effective against <italic>S. aureus</italic> and <italic>C. albicans</italic> and 100 times more active against <italic>E. coli</italic> than commercially used antimicrobial standard: Benzalkonium bromide.</p><p>Another example, where the (1<italic>S</italic>)-(+)-camphor-10-sulfonic acid was used as a precursor of <italic>N</italic>-heterocycle compounds, is the work where compounds from the group of (1<italic>S</italic>)-(+)-camphor-10-sulfonamide derivatives <bold>129</bold> (<xref ref-type="fig" rid="ijms-21-07078-f033">Figure 33</xref>) were investigated as antiviral inhibitors against filoviruses [<xref rid="B102-ijms-21-07078" ref-type="bibr">102</xref>]. The derivatives bearing morpholine <bold>129a</bold> and triazole <bold>129g</bold> moieties exhibit the highest inhibitory activity towards the Ebola virus glycoprotein, with the effectiveness level comparable to that of the reference drug. The excellent results presented in this paper allow us to predict that subsequent monoterpene bicyclic derivatives might be efficient inhibitors of especially dangerous viral infections.</p></sec><sec id="sec4dot4-ijms-21-07078"><title>4.4. Borneol</title><p>Borneol (1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol) is bicyclic monoterpenoid alcohol that exists as two enantiomers in the D and L forms that occur in the essential oils of numerous medicinal plants, such as valerian (<italic>Valeriana officinalis</italic> subsp. <italic>collina</italic> (Wallr.) Nyman), chamomile (<italic>Matricaria chamomilla</italic> L. Rydb.), and lavender (<italic>Lavandula officinalis</italic> Chaix). It has four configurations that correspond to different positions of the hydroxyl group. Borneol is used&#x02014;among others&#x02014;in perfume and cosmetics manufacturing, agriculture and wood, and pharmaceutical industries. In China&#x02019;s and India&#x02019;s traditional medicine, borneol has long since been used as a remedy against gastrointestinal diseases. (&#x02013;)-Borneol and its derivatives are antimicrobial [<xref rid="B103-ijms-21-07078" ref-type="bibr">103</xref>], anti-inflammatory [<xref rid="B104-ijms-21-07078" ref-type="bibr">104</xref>], and antiviral [<xref rid="B105-ijms-21-07078" ref-type="bibr">105</xref>]. Borneol has been shown to promote drugs crossing through the blood&#x02013;brain barrier, thus improving the efficiency of these drugs [<xref rid="B106-ijms-21-07078" ref-type="bibr">106</xref>].</p><p>The particular biological properties of (&#x02013;)-borneol derivatives belonging to the ester compounds significantly affect their applicability in medical areas, especially for diverse therapeutic fields [<xref rid="B104-ijms-21-07078" ref-type="bibr">104</xref>,<xref rid="B107-ijms-21-07078" ref-type="bibr">107</xref>,<xref rid="B108-ijms-21-07078" ref-type="bibr">108</xref>,<xref rid="B109-ijms-21-07078" ref-type="bibr">109</xref>]. (&#x02013;)-Borneol esters are also found in a few plant families: For instance, the hydroxycinnamic variety in <italic>Eupatorium deltoideum</italic> Poepp. ex Spreng. and <italic>Piper caninum</italic> Blume. Such natural esters show a broad spectrum of biological properties. Bornyl caffeate and coumarate are highly antibacterial [<xref rid="B110-ijms-21-07078" ref-type="bibr">110</xref>].</p><p>Bornyl salicylate&#x02014;commonly known salicylic derivative, obtained by esterification of salicylic acid and (&#x02013;)-borneol in the early 20th century&#x02014;was used topically in inflammatory diseases. Interestingly, it was only in 2012 that the first detailed analysis of the anti-inflammatory effects of bornyl salicylate (BS) in experimental models of acute inflammation was done [<xref rid="B104-ijms-21-07078" ref-type="bibr">104</xref>]. That research showed that signs of acute toxicity are not observed either in male or female mice. The authors revealed that the tested pharmaceutical compound is anti-inflammatory, which is related to the decrease in pro-inflammatory mediators because the treatment with bornyl salicylate is effective in the reduction of paw edema in both early and late phases.</p><p>A large set of monoterpene derivatives that belong to the group of (&#x02013;)-borneol esters were designed, synthesized, and examined with a view to their antimicrobial activity [<xref rid="B109-ijms-21-07078" ref-type="bibr">109</xref>]. Desired compounds were prepared by the conventional and microwave-assisted methodology and the obtained (&#x02013;)-borneol derivatives contained various aliphatic and aromatic moieties (<xref ref-type="fig" rid="ijms-21-07078-f034">Figure 34</xref>); all of them (<bold>130</bold>) were tested for their antibacterial and antifungal properties. Interestingly, among all examined monoterpene esters only those with methoxylated aromatic substituents (<bold>130a</bold>&#x02013;<bold>c</bold>) show noteworthy microbiological results. The antimicrobial assays confirmed that compounds <bold>130a</bold>, <bold>130b</bold>, and <bold>130c</bold> exhibit promising antibacterial activity for some microorganisms, which is comparable to commonly used standard&#x02014;ampicillin (MIC<sub>50</sub> = 62.5 &#x000b5;M). Bornyl 3&#x02032;,4&#x02032;-dimethoxybenzoate <bold>130b</bold> shows high antimicrobial activity against all tested bacteria and fungus.</p><p>The presented set of aliphatic and aromatic esters of (&#x02013;)-borneol derivatives (<xref ref-type="fig" rid="ijms-21-07078-f034">Figure 34</xref>) was also tested by the same research group for their antiproliferative and antioedematogenic properties [<xref rid="B108-ijms-21-07078" ref-type="bibr">108</xref>]. Compounds <bold>130c</bold> and <bold>130d</bold> show a pronounced cytostatic activity against various tumor cell lines, which makes them useful models for the development of alternative drugs that might be effective and highly promising in the treatment of cancer. Additionally, compound <bold>130d</bold> [(1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl benzoate] shows potential antioedematogenic activity being effective in the reduction of oedematogenic response in all evaluated periods. This aromatic ester of (&#x02013;)-borneol derivative might be useful in the development of new antiinflammatory drugs.</p><p>Another research group [<xref rid="B107-ijms-21-07078" ref-type="bibr">107</xref>] tested the in vitro effects of (1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>)-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-yl-3&#x02032;,4&#x02032;,5&#x02032;-trimethoxy benzoate <bold>130c</bold> and (1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>)-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-yl benzoate <bold>130d</bold> on the growth and ultrastructure of <italic>Trypanosoma cruzi</italic>. These two (&#x02013;)-borneol ester derivatives exerted an antiproliferative effect on the epimastigote forms of the parasite and might be used as a potential source for the development of more effective and safer chemotherapeutic agents against <italic>T. cruzi</italic> infections.</p><p>Another work showing a new (&#x02013;)-borneol ester derivative [<xref rid="B97-ijms-21-07078" ref-type="bibr">97</xref>] focuses on the efficient synthesis of bis((1<italic>R</italic>,4<italic>R</italic>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl) 2,4-diphenylcyclobutane-1,3-dicarboxylate <bold>131</bold> using <italic>&#x003b1;</italic>-truxillic acid and monoterpenoid bicyclic (&#x02013;)-borneol as the substrates (<xref ref-type="fig" rid="ijms-21-07078-f035">Figure 35</xref>). The new terpene compound obtained by Sokolova et al. exhibits a considerable analgesic activity. <italic>&#x003b1;</italic>-Truxillic acid (tested for the same dose) does not show analgesic activity, thus the monoterpenoid fragment is a structurally important element of the molecule, influencing its activity.</p><p>Another (&#x02013;)-borneol derivative with an ester group, namely bornyl (2<italic>Z</italic>)-4,4,4-trifluoro-2-[2-(4-methylphenyl)hydrazinylidene]-3-oxobutanoate <bold>132</bold> (<xref ref-type="fig" rid="ijms-21-07078-f036">Figure 36</xref>), was studied as an inhibitor of the main human isoenzymes involved in the biotransformation of ester-containing drugs: hCES1 and hCES2 [<xref rid="B10-ijms-21-07078" ref-type="bibr">10</xref>]. The tested ester derivative of natural occurring (&#x02013;)-borneol with the hydrazinylidene group is more active and selective against hCES1 than against hCES2. This compound inhibits hCES1 with the IC<sub>50</sub> values of 0.098 &#x000b1; 0.008 &#x003bc;M and has inhibitory activities against hCES2 with an IC<sub>50</sub> value of 2.10 &#x000b1; 0.18 &#x003bc;M.</p><p>It is commonly known that heterocyclic compounds and their various derivatives due to their beneficial biological, pharmacological, and medical properties have attracted great attention from medicinal chemistry. Commonly mentioned examples are derivatives of benzimidazole, benzoxazole, and benzothiazole, which possess a wide range of biological effects, mainly antiulcer, anti-inflammatory, antiviral activity, antihypertensive, and analgesic [<xref rid="B111-ijms-21-07078" ref-type="bibr">111</xref>,<xref rid="B112-ijms-21-07078" ref-type="bibr">112</xref>,<xref rid="B113-ijms-21-07078" ref-type="bibr">113</xref>,<xref rid="B114-ijms-21-07078" ref-type="bibr">114</xref>]. On the other hand, the presence of 1,7,7-trimethylbicyclo[2.2.1]heptane scaffold of designed molecules induces many biological activities of prepared compounds, for instance high inhibitory activity of molecules on the replication of influenza A virus [<xref rid="B88-ijms-21-07078" ref-type="bibr">88</xref>,<xref rid="B94-ijms-21-07078" ref-type="bibr">94</xref>,<xref rid="B95-ijms-21-07078" ref-type="bibr">95</xref>]. Hence, works where the compounds containing those two structural elements are broadly tested and significant biological activity are demonstrated. Importantly, most of such structural features of terpene-heterocyclic molecules also possess ester linker (<xref ref-type="fig" rid="ijms-21-07078-f037">Figure 37</xref>).</p><p>One of the works on this subject is an article studying various heterocyclic (&#x02013;)-borneol derivatives with benzothiazole, benzoxazole, benzimidazole, and other heterocycles moieties (<xref ref-type="fig" rid="ijms-21-07078-f038">Figure 38</xref>) [<xref rid="B105-ijms-21-07078" ref-type="bibr">105</xref>]. Those compounds were analyzed due to their biological properties, including their possible use as antiviral, antiulcer, and analgesic agents. The inhibition of the influenza virus replication was evaluated with the A/Puerto Rico/8/34 (H1N1) virus, while rimantadine, amantadine, and deitiforin were tested as reference compounds, due to the structural similarity of their rigid cage fragments relative to heterocyclic (&#x02013;)-borneol derivatives. Compound bearing two terpene moieties attached to 1<italic>H</italic>-benzimidazole-2-thiol core <bold>133b</bold> (<xref ref-type="fig" rid="ijms-21-07078-f038">Figure 38</xref>) exhibit considerable antiviral properties. Compounds with 1-methyl-1<italic>H</italic>-imidazole-2(3<italic>H</italic>)-thione <bold>133c</bold> and 1,2,4-triazole <bold>133d</bold> (<xref ref-type="fig" rid="ijms-21-07078-f038">Figure 38</xref>) fragments should be included as heterocyclic (&#x02013;)-borneol derivatives exhibiting high antiviral activity. Compound <bold>133a</bold> containing benzoxazole-2-thiol fragment shows significant antiulcer activity. The examination of the gastric mucosa of the animals treated with <bold>133a</bold> (&#x02013;)-borneol derivative prior to the indomethacin administration demonstrated a considerably reduced ulceration rate (PI 0.8) in comparison with the animals of the control group (PI 5.0). The results indicated that the antiulcer activity score of compound <bold>133a</bold> (AA with the value of 6.5) was higher than the same score for the reference compound (AA with a value of 3.8). While considering the analgesic activity of the presented (&#x02013;)-borneol derivatives only compound <bold>133d</bold> tends to induce hyperalgesia, reducing the time of animal pain response. Some compounds of the large group of (1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-yl 2-chloroacetates and (1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl 3-chloropropanoates combined with various <italic>N</italic>- and <italic>S</italic>-nucleophiles exhibit promising antiviral and antiulcer activity. Therefore, those heterocyclic (&#x02013;)-borneol derivatives should be considered as important and highly encouraging compounds for further development of more potent inhibitors of influenza viruses and antiulcer agents.</p><p>Another example presents various (&#x02013;)-borneol and (&#x02013;)-isoborneol (with different stereochemistries of the hydroxyl group) derivatives bearing a morpholine fragment as potential inhibitors of the influenza A virus (<xref ref-type="fig" rid="ijms-21-07078-f039">Figure 39</xref>) [<xref rid="B115-ijms-21-07078" ref-type="bibr">115</xref>]. Compounds <bold>134</bold>, <bold>135</bold>, and <bold>137</bold> exhibit particularly high antiviral activity against the influenza virus A/Puerto Rico/8/34 (H1N1). The structure&#x02013;activity analysis of those heterocyclic (&#x02013;)-borneol derivatives revealed that a bulky lipophilic unit in the form of 1,7,7-trimethylbicyclo[2.2.1]heptan scaffold is required to obtain high results of antiviral activity.</p><p>Borisova et al. presented the antiulcerogenic activity of heterocyclic (&#x02013;)-borneol derivatives [<xref rid="B116-ijms-21-07078" ref-type="bibr">116</xref>]. Some selected structures of the prepared set are shown in <xref ref-type="fig" rid="ijms-21-07078-f040">Figure 40</xref>. Compounds <bold>140</bold> and <bold>142</bold> containing piperazine moiety demonstrate antiulcerogenic activity on the indomethacin-induced ulcer model. Moreover, those (&#x02013;)-bornyl ester derivatives possess a considerable antiulcerogenic effect, which is comparable to that shown by Omeprazole and Famotidine, used as standards. Bornyl 2-piperazinoacetate with a non-substituted piperazine moiety <bold>140</bold> shows maximum antiulcerogenic activity. Furthermore, this ester has a significant gastroprotective effect on the ethanol-induced ulcer model, which was similar to the one presented by Omeprazole. Therefore, further biological research into this (&#x02013;)-borneol derivative containing piperazine moiety <bold>140</bold> should be aimed at the implementation of this compound as an antiulcerogenic agent.</p><p>Another work presents (&#x02013;)-bornyl ester derivatives with <italic>N</italic>-containing heterocycles as vaccinia virus (VV) inhibitors [<xref rid="B98-ijms-21-07078" ref-type="bibr">98</xref>]. Some of the structures of the large set designed and synthesized by Sokolova et al. are shown in <xref ref-type="fig" rid="ijms-21-07078-f041">Figure 41</xref>. Bioassay results confirmed that four (&#x02013;)-borneol derivatives (<bold>143</bold>, <bold>144</bold>) exhibit the best inhibitory activity against VV and low cytotoxicity. The authors emphasized two important structural issues that affect high anti-VV activity. Firstly, SAR studies suggest that the incorporation of the <italic>N</italic>-heterocyclic unit into the 1,7,7-trimethylbicyclo[2.2.1]heptane scaffold caused a significant improvement to antiviral activity. Secondly, (&#x02013;)-borneol does not exhibit activity against VV. Thus, the presence of both heterocyclic elements and 1,7,7-trimethylbicyclo[2.2.1]heptane fragment is responsible for the antiviral activity against VV. The effectiveness of presented esters (<xref ref-type="fig" rid="ijms-21-07078-f041">Figure 41</xref>, compounds <bold>143</bold> and <bold>144</bold>) is comparable to the reference drug Cidofovir and suggests that those (&#x02013;)-borneol heterocycle derivatives should be considered as potential anti-VV drug candidates.</p><p>Over 170 natural derivatives were screened in search of currently no approved antiviral therapy of Marburg virus disease (MVD) [<xref rid="B117-ijms-21-07078" ref-type="bibr">117</xref>]. The (&#x02013;)-bornyl ester derivatives containing saturated <italic>N</italic>-heterocycles exhibited the highest antiviral activity and can specifically inhibit MarV entry with the efficiency being comparable to that of the previously described verapamil. (&#x02013;)-Borneol itself is not active against both tested pseudotypes. Among low-toxic (&#x02013;)-borneol derivatives, some of the compounds inter alia <bold>138</bold>&#x02013;<bold>141</bold> turned out to be relatively specific inhibitors of MarV-GP mediated infection (SC &#x0003e; 10). Compound <bold>139</bold> containing a methylpiperidine moiety exhibits the highest virus-specific activity, which is twice as high as that of the reference.</p><p>Biological activities were also determined for another structural type of derivatives of (&#x02013;)-borneol. One of the examples is 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl methane sulfonate <bold>145</bold> (<xref ref-type="fig" rid="ijms-21-07078-f042">Figure 42</xref>), obtained from the reaction of (1<italic>S</italic>)-<italic>endo</italic>-(&#x02013;)-borneol with methanesulfonyl chloride [<xref rid="B118-ijms-21-07078" ref-type="bibr">118</xref>]. The antibacterial effect of compound <bold>145</bold> is comparable with that of the commonly used reference&#x02014;chloramphenicol.</p><p>Terpene compounds might also be used as substrates for the synthesis of specific polymer biomaterials as effective fouling resistant materials with lower cytotoxicity. An example of such an application is the utilization of natural borneol in designing a novel antibacterial material and developing an advanced strategy for antibacterial adhesion through polymer surface stereochemistry [<xref rid="B119-ijms-21-07078" ref-type="bibr">119</xref>]. The authors used <italic>endo</italic>-L-borneol: (1<italic>S</italic>,2<italic>R</italic>,4<italic>S</italic>), <italic>endo</italic>-D-borneol: (1<italic>R</italic>,2<italic>S</italic>,4<italic>R</italic>), and <italic>exo</italic>-isoborneol: (1<italic>S</italic>,2<italic>S</italic>,4<italic>S</italic>) and (1<italic>R</italic>,2<italic>R</italic>,4<italic>R</italic>) to prepare a series of borneol-based polymer polyborneolacrylates (PBAs) (<xref ref-type="fig" rid="ijms-21-07078-f043">Figure 43</xref>, compounds <bold>146</bold>) that showed unique antibacterial adhesion properties and significantly reduced bacterial attachment and biofilm formation. The PBA polymers were evaluated as noncytotoxic and should be considered a great potential for many biomedical applications. Superior antibacterial adhesion properties result from the borneol isomers on the material surface. This proof-of-concept improves polymer surface stereochemistry is an advanced strategy for antimicrobial adhesion, and the use of natural monoterpenes for this purpose is highly advisable.</p><p>This concept is confirmed by the other work done by the Wang group [<xref rid="B103-ijms-21-07078" ref-type="bibr">103</xref>], who presented (&#x02013;)-borneol grafting onto cellulose employing chloroacetyl chloride as a covalent linking agent in a two-step reaction. The obtained borneol-grafted cellulose (BGC) (<xref ref-type="fig" rid="ijms-21-07078-f043">Figure 43</xref>, compound <bold>147</bold>) material exhibits remarkable performance in antifungal adhesion and fungal growth inhibition, which suggests that grafted borneol moieties crucially influence the tactile sensing of fungal cells and, subsequently, their selectivity in adhesion. The simple modification consisting of adding small borneol molecules onto cellulose resulted in a significant conversion of the interfacial antifungal property and also opened a new opportunity for developing a new generation of antimicrobial celluloses. More crucially, both borneol and cellulose are natural products, therefore it should be concluded that it is possible to develop an advanced natural strategy for exploiting cellulose&#x02019;s potential use in antifungal adhesion and colonization. This environmentally friendly material might be applied in biomedicine and for sanitary purposes.</p><p>Sun et al. [<xref rid="B120-ijms-21-07078" ref-type="bibr">120</xref>] described borneol-modified poly(methyl methacrylate) PMMA based on a facile and effective stereochemical strategy, generating an antibacterial copolymer named P(MMA-<italic>co</italic>-BA)&#x02014;compound <bold>148</bold> (<xref ref-type="fig" rid="ijms-21-07078-f043">Figure 43</xref>). This copolymer, which effectively prevents bacterial adhesion and is environmentally benign, might be successfully applied for the prevention of bacterial colonization in biomedical devices. Its unique antibacterial character depends on the percentage of BA segments in the copolymer.</p><p>The borneol-based polymers are hydrophobic and noncytotoxic, which can significantly improve the cell adhesion ability [<xref rid="B121-ijms-21-07078" ref-type="bibr">121</xref>,<xref rid="B122-ijms-21-07078" ref-type="bibr">122</xref>]; on the other hand, borneol isomers on the material surface contribute to the surface bacterial resistance properties [<xref rid="B119-ijms-21-07078" ref-type="bibr">119</xref>,<xref rid="B120-ijms-21-07078" ref-type="bibr">120</xref>]. Due to those data, Meng et al. [<xref rid="B123-ijms-21-07078" ref-type="bibr">123</xref>] proposed polymerization with borneol based monomer, assuming that the hydrophobicity of zwitterionic polymers might increase, which will promote their cell adhesion ability without compromising their bacterial resistance properties. For this purpose, they synthesized hydrophobized zwitterionic copolymer P-(SBMA-<italic>co</italic>-DMA-<italic>co</italic>-ISA) (PSDI) (compound <bold>149</bold>, <xref ref-type="fig" rid="ijms-21-07078-f043">Figure 43</xref>), containing borneol based segment isobornyl acrylate (ISA) and zwitterionic moiety SBMA was prepared by sulfonation of P(DMA-<italic>co</italic>-ISA) (PDI). Together with tannic acid (TA), PSDI colloidal particles (CPs) were deposited onto the Ti alloy surface by electrophoretic deposition to form zwitterionic-based coatings. Due to the synergistic effect between the SBMA and chiral ISA functional units, tested composite coatings can effectively inhibit the adhesion of Gram-negative (<italic>E. coli</italic>) and -positive bacteria (<italic>S. aureus</italic>). Furthermore, cells can adhere and grow on the surface of CP-TA composite coating as a result of the appropriate hydrophobicity provided by the chiral monoterpene moiety. Meng et al., in their work, presented a new strategy for preparing zwitterionic-based multifunctional coating. The proposed composite coatings have great potential for metal implant surface modification to prevent bacterial infections.</p><p>Another example showed the development of stereochemical antimicrobial strategy by grafting (&#x02013;)-borneol 4-formylbenzoate to chitosan using a stable Schiff base bond (compound <bold>150</bold>, <xref ref-type="fig" rid="ijms-21-07078-f043">Figure 43</xref>) [<xref rid="B124-ijms-21-07078" ref-type="bibr">124</xref>]. The authors of that project received borneol-modified chitosan (BMC) as a potentially novel antimicrobial material. The biological tests were performed using Gram-negative <italic>E. coli</italic>, Gram-positive <italic>B. subtilis</italic>, and <italic>A. niger</italic>. BMC exhibits good antibacterial adhesion properties against both Gram-positive and Gram-negative bacteria. The BMC materials also demonstrate excellent antifungal adhesion performance (even for up to 29 days). Hence, modified chitosan with monoterpene moiety should be considered a broad-spectrum antimicrobial material. It enhances the protective effects of CF concerning the potential attachment of pathogens and maintains the skin flora. Therefore, BMC could have applications as a novel biomaterial-based on the stereochemical antimicrobial strategy and be useful in many biomedical and sanitary applications.</p><p>Another concept for creating an interesting biomaterial based on the (&#x02013;)-borneol component is graphene oxide-borneol (GOB) composite [<xref rid="B125-ijms-21-07078" ref-type="bibr">125</xref>], which can be synthesized by esterification of (&#x02013;)-borneol with thiomalic-acid-modified graphene oxide (GO) sheets, of which thiomalic acid is used as the linker molecule to increase the number of surface carboxyl groups. GOB exhibits antifungal adhesion and growth inhibition. It was proven that the carbon stereochemistry of the GOB was essential for the powerful antifungal performance while the covalent banding between GO and borneol molecules ensured its safe and long-term antifungal characteristics.</p></sec></sec><sec sec-type="conclusions" id="sec5-ijms-21-07078"><title>5. Conclusions</title><p>Terpenes make up the largest group of secondary metabolites (over 50,000 substances) and due to their naturally widespread occurrence, they have become central to research activities worldwide. It has been demonstrated that the use of the available and cheap monoterpenes as building blocks for designing and synthesizing new and effective agents to treat several diseases and some viral and bacterial infections is a promising and progressing direction in medicinal chemistry.</p><p>A crucial benefit from using described compounds is that their resource is almost inexhaustible, which has also ensured their wide application in industry. Moreover, the use of monoterpenoids to design drugs often reduces the toxicity of the resulting compound, which is an important factor when considering the possible utilization and manufacture of new compounds. It is widely known that chemical modification of natural substances with various components is an important method for obtaining new biologically active compounds. This feature is particularly visible in the monoterpene derivatives presented in this review. Their biological activities are often much superior to the parent substances (monoterpenes); furthermore, they often exceed the commonly used standards in specialized areas of research.</p><p>The increased strength of activity is observed by supplement functionalized moiety (e.g., heterocyclic unit introduced into thymol, camphor, or borneol derivatives) or special group, like an ester group in borneol derivatives, or an imino group in camphor derivatives. Nowadays, this is a promising route as this is of utmost importance to utilize natural substances for discovering new compounds and to search for practical uses for the newly obtained materials. As presented in this paper, monoterpenes exhibit a large variety of biological activities that can be exploited in various branches of medicine and pharmacy. This review highlights the use of the selected beneficial monoterpenes and their derivatives for the treatment of various diseases. It should be mentioned that alongside the biological activities presented in this paper, the substances play important roles in preventing and remediating other diseases such as those of the heart and diabetes. Obtaining new structures based on monoterpene compounds is a dynamically developing area, and one should expect new interesting biological applications, as well as modifications to structures that will improve current results in biological research.</p></sec></body><back><ack><title>Acknowledgments</title><p>Authors are grateful for the financial support given by the Polish Ministry of Science and Higher Education by subvention activity for the Faculty of Chemistry at Wroc&#x00142;aw University of Science and Technology.</p></ack><notes><title>Funding</title><p>Polish Ministry of Science and Higher Education-subvention activity for the Faculty of Chemistry at Wroc&#x00142;aw University of Science and Technology.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AA</td><td align="left" valign="middle" rowspan="1" colspan="1">the antiulcer activity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AChE</td><td align="left" valign="middle" rowspan="1" colspan="1">acetylcholinesterase enzymes</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">A/Puerto Rico/8/34 (H1N1) virus</td><td align="left" valign="middle" rowspan="1" colspan="1">influenza A virus, subtype</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BA</td><td align="left" valign="middle" rowspan="1" colspan="1">borneol acrylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BGC</td><td align="left" valign="middle" rowspan="1" colspan="1">borneol-grafted cellulose</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMC</td><td align="left" valign="middle" rowspan="1" colspan="1">borneol-modified chitosan</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BS</td><td align="left" valign="middle" rowspan="1" colspan="1">bornyl salicylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BuChE</td><td align="left" valign="middle" rowspan="1" colspan="1">butyrylcholinesterase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CEM-13</td><td align="left" valign="middle" rowspan="1" colspan="1">the cells of T-cellular human leucosis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CES</td><td align="left" valign="middle" rowspan="1" colspan="1">inhibitory activity against porcine liver</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CF</td><td align="left" valign="middle" rowspan="1" colspan="1">chitosan fabric</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CNS</td><td align="left" valign="middle" rowspan="1" colspan="1">central nervous system</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">COX-2</td><td align="left" valign="middle" rowspan="1" colspan="1">cyclooxygenase-2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPs</td><td align="left" valign="middle" rowspan="1" colspan="1">colloidal particles</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DEET</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>N</italic>,<italic>N</italic>-diethyl-3-methylbenzamide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMA</td><td align="left" valign="middle" rowspan="1" colspan="1">2-(dimethylamino)ethyl methacrylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DPPH</td><td align="left" valign="middle" rowspan="1" colspan="1">2,2-diphenyl-1-picrylhydrazyl</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EO</td><td align="left" valign="middle" rowspan="1" colspan="1">essential oil</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPM test</td><td align="left" valign="middle" rowspan="1" colspan="1">elevated plus maze test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ESBL</td><td align="left" valign="middle" rowspan="1" colspan="1">extended-spectrum beta-lactamases</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">fMLP/CB</td><td align="left" valign="middle" rowspan="1" colspan="1">formyl-l-methionyl-l-leucyl-l-phenylalanine/cytochalasin B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GO</td><td align="left" valign="middle" rowspan="1" colspan="1">graphene oxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GOB</td><td align="left" valign="middle" rowspan="1" colspan="1">graphene oxide-borneol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">H5N2</td><td align="left" valign="middle" rowspan="1" colspan="1">influenza A virus, subtype</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">hCA I and II</td><td align="left" valign="middle" rowspan="1" colspan="1">cytosolic carbonic anhydrase I and II isoforms</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISA</td><td align="left" valign="middle" rowspan="1" colspan="1">isobornyl acrylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LPS</td><td align="left" valign="middle" rowspan="1" colspan="1">lipopolysaccharide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MARV</td><td align="left" valign="middle" rowspan="1" colspan="1">Marburg virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MMA</td><td align="left" valign="middle" rowspan="1" colspan="1">methyl methacrylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MRSA</td><td align="left" valign="middle" rowspan="1" colspan="1">methicyllin-resistant <italic>S. aureus</italic></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MTT</td><td align="left" valign="middle" rowspan="1" colspan="1">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NO</td><td align="left" valign="middle" rowspan="1" colspan="1">nitric oxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PBA</td><td align="left" valign="middle" rowspan="1" colspan="1">polyborneolacrylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">P-(SBMA-<italic>co</italic>-DMA-<italic>co</italic>-ISA) (PSDI)</td><td align="left" valign="middle" rowspan="1" colspan="1">poly(sulfobetaine methacrylate-<italic>co</italic>-2-(dimethylamino)ethyl methacrylate-<italic>co</italic>-isobornyl acrylate)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PDI P(DMA-<italic>co</italic>-ISA)</td><td align="left" valign="middle" rowspan="1" colspan="1">hydrophobized zwitterionic copolymer</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PI</td><td align="left" valign="middle" rowspan="1" colspan="1">Paul&#x02019;s index in testes of antiulcer activity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMMA</td><td align="left" valign="middle" rowspan="1" colspan="1">poly(methyl methacrylate)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SAR</td><td align="left" valign="middle" rowspan="1" colspan="1">structure-activity relationship</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SBMA</td><td align="left" valign="middle" rowspan="1" colspan="1">sulfobetaine</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SRB</td><td align="left" valign="middle" rowspan="1" colspan="1">sulforhodamine B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TA</td><td align="left" valign="middle" rowspan="1" colspan="1">tannic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">THQ</td><td align="left" valign="middle" rowspan="1" colspan="1">thymohydroquinone dimethyl ether</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VV</td><td align="left" valign="middle" rowspan="1" colspan="1">vaccinia virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="middle" rowspan="1" colspan="1">Zika virus</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-ijms-21-07078"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozio&#x00142;</surname><given-names>A.</given-names></name><name><surname>Stryjewska</surname><given-names>A.</given-names></name><name><surname>Librowski</surname><given-names>T.</given-names></name><name><surname>Sa&#x00142;at</surname><given-names>K.</given-names></name><name><surname>Gawe&#x00142;</surname><given-names>M.</given-names></name><name><surname>Moniczewski</surname><given-names>A.</given-names></name><name><surname>Lochy&#x00144;ski</surname><given-names>S.</given-names></name></person-group><article-title>An overview of the pharmacological properties and potential applications of natural monoterpenes</article-title><source>Med. Chem.</source><year>2014</year><volume>14</volume><fpage>1156</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.2174/1389557514666141127145820</pub-id></element-citation></ref><ref id="B2-ijms-21-07078"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtunik-Kulesza</surname><given-names>K.A.</given-names></name><name><surname>Kasprzak</surname><given-names>K.</given-names></name><name><surname>Oniszczuk</surname><given-names>T.</given-names></name><name><surname>Oniszczuk</surname><given-names>A.</given-names></name></person-group><article-title>Natural monoterpenes: Much more than only a scent</article-title><source>Chem. Biodivers.</source><year>2019</year><volume>16</volume><fpage>e1900434</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201900434</pub-id><?supplied-pmid 31587473?><pub-id pub-id-type="pmid">31587473</pub-id></element-citation></ref><ref id="B3-ijms-21-07078"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto</surname><given-names>R.S.S.</given-names></name><name><surname>Albuquerque-J&#x000fa;nior</surname><given-names>R.L.C.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>A.A.S.</given-names></name><name><surname>Almeida</surname><given-names>J.R.G.S.</given-names></name><name><surname>Santos</surname><given-names>M.R.V.</given-names></name><name><surname>Barreto</surname><given-names>A.S.</given-names></name><name><surname>DeSantana</surname><given-names>J.M.</given-names></name><name><surname>Siqueira-Lima</surname><given-names>P.S.</given-names></name><name><surname>Quintans</surname><given-names>J.S.S.</given-names></name><name><surname>Quintans-J&#x000fa;nior</surname><given-names>L.J.</given-names></name></person-group><article-title>A systematic review of the wound-healing effects of monoterpenes and iridoid derivatives</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>846</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.3390/molecules19010846</pub-id><?supplied-pmid 24419138?><pub-id pub-id-type="pmid">24419138</pub-id></element-citation></ref><ref id="B4-ijms-21-07078"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragomanova</surname><given-names>S.</given-names></name><name><surname>Tancheva</surname><given-names>L.</given-names></name><name><surname>Georgieva</surname><given-names>M.</given-names></name></person-group><article-title>A review: Biological activity of myrtenal and some myrtenal-containing medicinal plant essential oils</article-title><source>Scr. Sci. Pharm.</source><year>2018</year><volume>5</volume><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.14748/ssp.v5i2.5614</pub-id></element-citation></ref><ref id="B5-ijms-21-07078"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Di Lorenzo</surname><given-names>A.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Gortzi</surname><given-names>O.</given-names></name><name><surname>Izadi</surname><given-names>M.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name></person-group><article-title>Antibacterial and antifungal activities of thymol: A brief review of the literature</article-title><source>Food Chem.</source><year>2016</year><volume>210</volume><fpage>402</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.04.111</pub-id><pub-id pub-id-type="pmid">27211664</pub-id></element-citation></ref><ref id="B6-ijms-21-07078"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dheer</surname><given-names>J.D.</given-names></name><name><surname>Singh</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Karnatak</surname><given-names>M.</given-names></name><name><surname>Chandra</surname><given-names>S.</given-names></name><name><surname>Verma</surname><given-names>V.P.</given-names></name><name><surname>Shankar</surname><given-names>R.</given-names></name></person-group><article-title>Thymol chemistry: A medicinal toolbox</article-title><source>Curr. Bioact. Compd.</source><year>2019</year><volume>15</volume><fpage>454</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.2174/1573407214666180503120222</pub-id></element-citation></ref><ref id="B7-ijms-21-07078"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Der Heijden</surname><given-names>R.</given-names></name><name><surname>Jacobs</surname><given-names>D.I.</given-names></name><name><surname>Snoeijer</surname><given-names>W.</given-names></name><name><surname>Hallard</surname><given-names>D.</given-names></name><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group><article-title>The Catharanthus alkaloids: Pharmacognosy and biotechnology</article-title><source>Curr. Med. Chem.</source><year>2004</year><volume>11</volume><fpage>607</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.2174/0929867043455846</pub-id><pub-id pub-id-type="pmid">15032608</pub-id></element-citation></ref><ref id="B8-ijms-21-07078"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnesecchi</surname><given-names>S.</given-names></name><name><surname>Bras-Goncalves</surname><given-names>R.</given-names></name><name><surname>Bradaia</surname><given-names>A.</given-names></name><name><surname>Zeisel</surname><given-names>M.</given-names></name><name><surname>Gosse</surname><given-names>F.</given-names></name><name><surname>Poupon</surname><given-names>M.F.</given-names></name><name><surname>Raul</surname><given-names>F.</given-names></name></person-group><article-title>Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts</article-title><source>Cancer Lett.</source><year>2004</year><volume>215</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2004.06.019</pub-id><pub-id pub-id-type="pmid">15374632</pub-id></element-citation></ref><ref id="B9-ijms-21-07078"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>P.</given-names></name><name><surname>Jun</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>P.</given-names></name></person-group><article-title>Pharmacological properties of geraniol&#x02014;A review</article-title><source>Planta Med.</source><year>2019</year><volume>85</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1055/a-0750-6907</pub-id><pub-id pub-id-type="pmid">30308694</pub-id></element-citation></ref><ref id="B10-ijms-21-07078"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makhaeva</surname><given-names>G.F.</given-names></name><name><surname>Elkina</surname><given-names>N.A.</given-names></name><name><surname>Shchegolkov</surname><given-names>E.V.</given-names></name><name><surname>Boltneva</surname><given-names>N.P.</given-names></name><name><surname>Lushchekina</surname><given-names>S.V.</given-names></name><name><surname>Serebryakova</surname><given-names>O.G.</given-names></name><name><surname>Rudakova</surname><given-names>E.V.</given-names></name><name><surname>Kovaleva</surname><given-names>N.V.</given-names></name><name><surname>Radchenko</surname><given-names>E.V.</given-names></name><name><surname>Palyulin</surname><given-names>V.A.</given-names></name><etal/></person-group><article-title>Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors</article-title><source>Bioorg. Chem.</source><year>2019</year><volume>91</volume><fpage>103097</fpage><lpage>103110</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103097</pub-id><pub-id pub-id-type="pmid">31323527</pub-id></element-citation></ref><ref id="B11-ijms-21-07078"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez</surname><given-names>M.I.</given-names></name><name><surname>Soto</surname><given-names>M.</given-names></name><name><surname>Cimino</surname><given-names>F.A.</given-names></name><name><surname>Olea</surname><given-names>A.F.</given-names></name><name><surname>Espinoza</surname><given-names>L.</given-names></name><name><surname>D&#x000ed;az</surname><given-names>K.</given-names></name><name><surname>Taborga</surname><given-names>L.</given-names></name></person-group><article-title>In Vitro antifungal activity of new and known geranylated phenols against <italic>Phytophthora cinnamomi</italic> rands</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>1601</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19061601</pub-id><?supplied-pmid 29844282?><pub-id pub-id-type="pmid">29844282</pub-id></element-citation></ref><ref id="B12-ijms-21-07078"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamura</surname><given-names>H.</given-names></name><name><surname>Ohashi</surname><given-names>T.</given-names></name><name><surname>Kikuchi</surname><given-names>T.</given-names></name><name><surname>Endo</surname><given-names>N.</given-names></name><name><surname>Fukuda</surname><given-names>Y.</given-names></name><name><surname>Kadota</surname><given-names>I.</given-names></name></person-group><article-title>Late-stage divergent synthesis and antifouling activity of geraniol&#x02013;butenolide hybrid molecules</article-title><source>Org. Biomol. Chem.</source><year>2017</year><volume>15</volume><fpage>5549</fpage><lpage>5555</lpage><pub-id pub-id-type="doi">10.1039/C7OB01160A</pub-id><?supplied-pmid 28632269?><pub-id pub-id-type="pmid">28632269</pub-id></element-citation></ref><ref id="B13-ijms-21-07078"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>T.</given-names></name></person-group><article-title>Catalytic properties of metal sulfates supported on &#x003b3;-Al<sub>2</sub>O<sub>3</sub> in the liquid-phase isopropylation of <italic>m</italic>-cresol with propylene</article-title><source>Bull Chem. Soc. Jpn.</source><year>1976</year><volume>49</volume><fpage>2669</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.1246/bcsj.49.2669</pub-id></element-citation></ref><ref id="B14-ijms-21-07078"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabowska</surname><given-names>H.</given-names></name><name><surname>Mi&#x0015b;ta</surname><given-names>W.</given-names></name><name><surname>Trawczy&#x00144;ski</surname><given-names>J.</given-names></name><name><surname>Wrzyszcz</surname><given-names>J.</given-names></name><name><surname>Zawadzki</surname><given-names>M.</given-names></name></person-group><article-title>A method for obtaining thymol by gas phase catalytic alkylation of <italic>m</italic>-cresol over zinc aluminate spinel</article-title><source>Appl. Catal. A Gen.</source><year>2001</year><volume>220</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/S0926-860X(01)00722-0</pub-id></element-citation></ref><ref id="B15-ijms-21-07078"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amandi</surname><given-names>R.</given-names></name><name><surname>Hyde</surname><given-names>J.R.</given-names></name><name><surname>Ross</surname><given-names>S.K.</given-names></name><name><surname>Lotz</surname><given-names>T.J.</given-names></name><name><surname>Poliakoff</surname><given-names>M.</given-names></name></person-group><article-title>Continuous reactions in supercritical fluids; a cleaner, more selective synthesis of thymol in supercritical CO<sub>2</sub></article-title><source>Green Chem.</source><year>2005</year><volume>7</volume><fpage>288</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1039/b418983c</pub-id></element-citation></ref><ref id="B16-ijms-21-07078"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>T.A.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Doppler</surname><given-names>M.</given-names></name><name><surname>Scofield</surname><given-names>S.R.</given-names></name></person-group><article-title>Thymol-based submicron emulsions exhibit antifungal activity against <italic>Fusarium graminearum</italic> and inhibit <italic>Fusarium</italic> head blight in wheat</article-title><source>J. Appl. Microbiol.</source><year>2016</year><volume>121</volume><fpage>1103</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1111/jam.13195</pub-id><pub-id pub-id-type="pmid">27253757</pub-id></element-citation></ref><ref id="B17-ijms-21-07078"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lira Mota</surname><given-names>K.S.</given-names></name><name><surname>de Oliveira Pereira</surname><given-names>F.</given-names></name><name><surname>de Oliveira</surname><given-names>W.A.</given-names></name><name><surname>Lima</surname><given-names>I.O.</given-names></name><name><surname>de Oliveira Lima</surname><given-names>E.</given-names></name></person-group><article-title>Antifungal activity of <italic>Thymus vulgaris</italic> L. essential oil and its constituent phytochemicals against <italic>Rhizopus oryzae</italic>: Interaction with ergosterol</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>14418</fpage><lpage>14433</lpage><pub-id pub-id-type="doi">10.3390/molecules171214418</pub-id><pub-id pub-id-type="pmid">23519243</pub-id></element-citation></ref><ref id="B18-ijms-21-07078"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wattanasatcha</surname><given-names>A.</given-names></name><name><surname>Rengpipat</surname><given-names>S.</given-names></name><name><surname>Wanichwecharungruang</surname><given-names>S.</given-names></name></person-group><article-title>Thymol nanospheres as an effective antibacterial agent</article-title><source>Int. J. Pharm.</source><year>2012</year><volume>434</volume><fpage>360</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.06.017</pub-id><pub-id pub-id-type="pmid">22698863</pub-id></element-citation></ref><ref id="B19-ijms-21-07078"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miladi</surname><given-names>H.</given-names></name><name><surname>Zmantar</surname><given-names>T.</given-names></name><name><surname>Kouidhi</surname><given-names>B.</given-names></name><name><surname>Chaabouni</surname><given-names>Y.</given-names></name><name><surname>Mahdouani</surname><given-names>K.</given-names></name><name><surname>Bakhrouf</surname><given-names>A.</given-names></name><name><surname>Chaieb</surname><given-names>K.</given-names></name></person-group><article-title>Use of carvacrol, thymol, and eugenol for biofilm eradication and resistance modifying susceptibility of <italic>Salmonella enterica</italic> of serovar <italic>Typhimurium</italic> strains to nalidixic acid</article-title><source>Microb. Pathog.</source><year>2017</year><volume>104</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.01.012</pub-id><pub-id pub-id-type="pmid">28062292</pub-id></element-citation></ref><ref id="B20-ijms-21-07078"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veras</surname><given-names>H.N.</given-names></name><name><surname>Araruna</surname><given-names>M.K.</given-names></name><name><surname>Costa</surname><given-names>J.G.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.</given-names></name><name><surname>Kerntopf</surname><given-names>M.R.</given-names></name><name><surname>Botelho</surname><given-names>M.A.</given-names></name><name><surname>Menezes</surname><given-names>I.R.</given-names></name></person-group><article-title>Topical antiinflammatory activity of essential oil of <italic>Lippia sidoides</italic> cham: Possible mechanism of action</article-title><source>Phytother. Res.</source><year>2013</year><volume>27</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/ptr.4695</pub-id><pub-id pub-id-type="pmid">22511564</pub-id></element-citation></ref><ref id="B21-ijms-21-07078"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname><given-names>M.A.</given-names></name><name><surname>Barros</surname><given-names>G.</given-names></name><name><surname>Queiroz</surname><given-names>D.B.</given-names></name><name><surname>Carvalho</surname><given-names>C.F.</given-names></name><name><surname>Gouvea</surname><given-names>J.</given-names></name><name><surname>Patrus</surname><given-names>L.</given-names></name><name><surname>Bannet</surname><given-names>M.</given-names></name><name><surname>Patrus</surname><given-names>D.</given-names></name><name><surname>Rego</surname><given-names>A.</given-names></name><name><surname>Silva</surname><given-names>I.</given-names></name></person-group><article-title>Nanotechnology in phytotherapy: Antiinflammatory effect of a nanostructured thymol gel from <italic>Lippia sidoides</italic> in acute periodontitis in rats</article-title><source>Phytother. Res.</source><year>2016</year><volume>30</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1002/ptr.5516</pub-id><?supplied-pmid 26553130?><pub-id pub-id-type="pmid">26553130</pub-id></element-citation></ref><ref id="B22-ijms-21-07078"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riella</surname><given-names>K.</given-names></name><name><surname>Marinho</surname><given-names>R.</given-names></name><name><surname>Santos</surname><given-names>J.</given-names></name><name><surname>Pereira-Filho</surname><given-names>R.</given-names></name><name><surname>Cardoso</surname><given-names>J.</given-names></name><name><surname>Albuquerque-Junior</surname><given-names>R.</given-names></name><name><surname>Homazzi</surname><given-names>S.</given-names></name></person-group><article-title>Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from <italic>Lippia gracilis</italic>, in rodents</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>143</volume><fpage>656</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.07.028</pub-id><?supplied-pmid 22885071?><pub-id pub-id-type="pmid">22885071</pub-id></element-citation></ref><ref id="B23-ijms-21-07078"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Rawat</surname><given-names>D.S.</given-names></name></person-group><article-title>Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases</article-title><source>Biorgan. Med. Chem.</source><year>2013</year><volume>23</volume><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.12.001</pub-id></element-citation></ref><ref id="B24-ijms-21-07078"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>L.-L.</given-names></name><name><surname>Taxipalati</surname><given-names>M.</given-names></name><name><surname>Que</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>Physical characterization and antioxidant activity of thymol solubilized Tween 80 micelles</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>38160</fpage><lpage>38168</lpage><pub-id pub-id-type="doi">10.1038/srep38160</pub-id><pub-id pub-id-type="pmid">27905567</pub-id></element-citation></ref><ref id="B25-ijms-21-07078"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>E.K.</given-names></name><name><surname>Hwang</surname><given-names>J.W.</given-names></name><name><surname>Jeong</surname><given-names>J.H.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Park</surname><given-names>P.J.</given-names></name></person-group><article-title>Anticancer effect of thymol on AGS human gastric carcinoma cells</article-title><source>J. Microbiol. Biotech.</source><year>2016</year><volume>26</volume><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.4014/jmb.1506.06073</pub-id></element-citation></ref><ref id="B26-ijms-21-07078"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name></person-group><article-title>The fungicidal activity of thymol against <italic>Fusarium graminearum</italic> via inducing lipid peroxidation and disrupting ergosterol biosynthesis</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>770</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21060770</pub-id></element-citation></ref><ref id="B27-ijms-21-07078"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name></person-group><article-title>Antimicrobial activities of some thymol derivatives from the roots of <italic>Inula hupehensis</italic></article-title><source>Food Chem.</source><year>2010</year><volume>120</volume><fpage>512</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.10.045</pub-id></element-citation></ref><ref id="B28-ijms-21-07078"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathela</surname><given-names>C.S.</given-names></name><name><surname>Singh</surname><given-names>K.K.</given-names></name><name><surname>Gupta</surname><given-names>V.K.</given-names></name></person-group><article-title>Synthesis and in vitro antibacterial activity of thymol and carvacrol derivatives</article-title><source>Acta Pol. Pharm.</source><year>2010</year><volume>67</volume><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">20635533</pub-id></element-citation></ref><ref id="B29-ijms-21-07078"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>K.R.</given-names></name><name><surname>Le</surname><given-names>T.C.</given-names></name><name><surname>Chintakunta</surname><given-names>P.K.</given-names></name><name><surname>Lakshman</surname><given-names>D.K.</given-names></name></person-group><article-title>Phyto-fungicides: Structure activity relationships of the thymol derivatives against <italic>Rhizoctonia solani</italic></article-title><source>J. Agric. Chem. Environ.</source><year>2017</year><volume>6</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.4236/jacen.2017.64012</pub-id></element-citation></ref><ref id="B30-ijms-21-07078"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagle</surname><given-names>P.</given-names></name><name><surname>Pawar</surname><given-names>Y.</given-names></name><name><surname>Sonawane</surname><given-names>A.</given-names></name><name><surname>Bhosale</surname><given-names>S.</given-names></name><name><surname>More</surname><given-names>D.</given-names></name></person-group><article-title>Synthesis and evaluation of antioxidant and antimicrobial properties of thymol containing pyridone moieties</article-title><source>Med. Chem. Res.</source><year>2012</year><volume>21</volume><fpage>1395</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1007/s00044-011-9656-7</pub-id></element-citation></ref><ref id="B31-ijms-21-07078"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epps</surname><given-names>S.V.</given-names></name><name><surname>Harvey</surname><given-names>R.B.</given-names></name><name><surname>Byrd</surname><given-names>J.A.</given-names></name><name><surname>Petrujki&#x00107;</surname><given-names>B.T.</given-names></name><name><surname>Sedej</surname><given-names>I.</given-names></name><name><surname>Beier</surname><given-names>R.C.</given-names></name><name><surname>Phillips</surname><given-names>T.D.</given-names></name><name><surname>Hume</surname><given-names>M.E.</given-names></name><name><surname>Anderson</surname><given-names>R.C.</given-names></name><name><surname>Nisbet</surname><given-names>D.J.</given-names></name></person-group><article-title>Comparative effect of thymol or its glucose conjugate, thymol-&#x003b2;-D-glucopyranoside, on Campylobacter in avian gut contents</article-title><source>J. Environ. Sci. HealthPart. B</source><year>2015</year><volume>50</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1080/03601234.2015.965634</pub-id></element-citation></ref><ref id="B32-ijms-21-07078"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>L.M.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Q.L.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Luo</surname><given-names>B.</given-names></name><name><surname>Luo</surname><given-names>Q.W.</given-names></name><name><surname>Liu</surname><given-names>W.B.</given-names></name><name><surname>Tan</surname><given-names>J.W.</given-names></name></person-group><article-title>Two new thymol derivatives from the roots of <italic>Ageratina adenophora</italic></article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>592</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22040592</pub-id></element-citation></ref><ref id="B33-ijms-21-07078"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.C.</given-names></name><name><surname>Zhou</surname><given-names>X.R.</given-names></name><name><surname>Xu</surname><given-names>X.J.</given-names></name><name><surname>Fu</surname><given-names>Q.Y.</given-names></name><name><surname>Liu</surname><given-names>C.Z.</given-names></name></person-group><article-title>Two thymol derivatives from the flower buds of <italic>Lonicera japonica</italic> and their antibacterial activity</article-title><source>Nat. Prod. Res.</source><year>2018</year><volume>32</volume><fpage>2238</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1371153</pub-id><?supplied-pmid 28868923?><pub-id pub-id-type="pmid">28868923</pub-id></element-citation></ref><ref id="B34-ijms-21-07078"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bkhaitan</surname><given-names>M.M.</given-names></name><name><surname>Alarjah</surname><given-names>M.</given-names></name><name><surname>Mirza</surname><given-names>A.Z.</given-names></name><name><surname>Abdalla</surname><given-names>A.N.</given-names></name><name><surname>El-Said</surname><given-names>H.M.</given-names></name><name><surname>Hani</surname><given-names>S.</given-names></name><name><surname>Faidah</surname><given-names>H.S.</given-names></name></person-group><article-title>Preparation and biological evaluation of metronidazole derivatives with monoterpenes and eugenol</article-title><source>Chem. Biol. Drug Des.</source><year>2018</year><volume>92</volume><fpage>1954</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1111/cbdd.13366</pub-id><?supplied-pmid 30022596?><pub-id pub-id-type="pmid">30022596</pub-id></element-citation></ref><ref id="B35-ijms-21-07078"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Miligy</surname><given-names>M.M.M.</given-names></name><name><surname>Hazzaa</surname><given-names>A.A.</given-names></name><name><surname>El-Zemity</surname><given-names>S.R.</given-names></name><name><surname>Al-Kubeisi</surname><given-names>A.K.</given-names></name></person-group><article-title>Synthesis of thymol derivatives as potential non-irritant antimicrobial and insecticidal agents</article-title><source>Curr. Bioact. Compd.</source><year>2019</year><volume>15</volume><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.2174/1573407213666171115161626</pub-id></element-citation></ref><ref id="B36-ijms-21-07078"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>S.S.</given-names></name><name><surname>Paidesetty</surname><given-names>S.K.</given-names></name><name><surname>Padhy</surname><given-names>R.N.</given-names></name></person-group><article-title>Synthesis of novel thymol derivatives against MRSA and ESBL producing pathogenic bacteria</article-title><source>Nat. Prod. Res.</source><year>2019</year><volume>33</volume><fpage>3181</fpage><lpage>3189</lpage><pub-id pub-id-type="doi">10.1080/14786419.2018.1474465</pub-id><?supplied-pmid 29792335?><pub-id pub-id-type="pmid">29792335</pub-id></element-citation></ref><ref id="B37-ijms-21-07078"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H.</given-names></name><name><surname>Lim</surname><given-names>S.M.</given-names></name><name><surname>Ramasamy</surname><given-names>K.</given-names></name><name><surname>Vasudevan</surname><given-names>M.</given-names></name><name><surname>Shah</surname><given-names>S.A.A.</given-names></name><name><surname>Narasimhan</surname><given-names>B.</given-names></name></person-group><article-title>Diazenyl schiff bases: Synthesis, spectral analysis, antimicrobial studies and cytotoxic activity on human colorectal carcinoma cell line (HCT-116)</article-title><source>Arab. J. Chem.</source><year>2020</year><volume>13</volume><fpage>377</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2017.05.004</pub-id></element-citation></ref><ref id="B38-ijms-21-07078"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Nishida</surname><given-names>Y.</given-names></name></person-group><article-title>Synthesis and bioactivity of novel carvacrol and thymol derivatives containing 5-phenyl-2-furan</article-title><source>Lett. Drug Des. Discov.</source><year>2014</year><volume>11</volume><fpage>877</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.2174/1570180811666140220005252</pub-id></element-citation></ref><ref id="B39-ijms-21-07078"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>L.</given-names></name><name><surname>Su</surname><given-names>F.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis and antifungal activity of carvacrol and thymol esters with heteroaromatic carboxylic acids</article-title><source>Nat. Prod. Res.</source><year>2019</year><volume>33</volume><fpage>1924</fpage><lpage>1930</lpage><pub-id pub-id-type="doi">10.1080/14786419.2018.1480618</pub-id><pub-id pub-id-type="pmid">29874939</pub-id></element-citation></ref><ref id="B40-ijms-21-07078"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javan</surname><given-names>A.J.</given-names></name><name><surname>Javan</surname><given-names>M.J.</given-names></name></person-group><article-title>Electronic structure of some thymol derivatives correlated with the radical scavenging activity: Theoretical study</article-title><source>Food Chem.</source><year>2014</year><volume>165</volume><fpage>451</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.05.073</pub-id><pub-id pub-id-type="pmid">25038698</pub-id></element-citation></ref><ref id="B41-ijms-21-07078"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>Z.</given-names></name><name><surname>Rafiq</surname><given-names>M.</given-names></name><name><surname>Seo</surname><given-names>S.-Y.</given-names></name><name><surname>Kwon</surname><given-names>K.S.</given-names></name><name><surname>Babar</surname><given-names>M.M.</given-names></name><name><surname>Zaidi</surname><given-names>N.U.</given-names></name></person-group><article-title>Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase</article-title><source>Eur. J. Med. Chem.</source><year>2015</year><volume>98</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2015.05.031</pub-id><?supplied-pmid 26025140?><pub-id pub-id-type="pmid">26025140</pub-id></element-citation></ref><ref id="B42-ijms-21-07078"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathe</surname><given-names>P.S.</given-names></name><name><surname>Rajput</surname><given-names>J.D.</given-names></name><name><surname>Gunaga</surname><given-names>S.S.</given-names></name><name><surname>Patel</surname><given-names>H.M.</given-names></name><name><surname>Bendre</surname><given-names>R.S.</given-names></name></person-group><article-title>Synthesis, characterization, and antioxidant activity of thymol-based paracetamol analogues</article-title><source>Res. Chem. Intermed.</source><year>2019</year><volume>45</volume><fpage>5487</fpage><lpage>5498</lpage><pub-id pub-id-type="doi">10.1007/s11164-019-03914-0</pub-id></element-citation></ref><ref id="B43-ijms-21-07078"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.C.</given-names></name><name><surname>Lee</surname><given-names>T.H.</given-names></name><name><surname>Sung</surname><given-names>P.J.</given-names></name><name><surname>Shu</surname><given-names>C.W.</given-names></name><name><surname>Lim</surname><given-names>Y.P.</given-names></name><name><surname>Cheng</surname><given-names>M.J.</given-names></name><name><surname>Kuo</surname><given-names>W.L.</given-names></name><name><surname>Chen</surname><given-names>J.J.</given-names></name></person-group><article-title>New thymol derivatives and cytotoxic constituents from the root of <italic>Eupatorium cannabinum</italic> ssp. <italic>asiaticum</italic></article-title><source>Chem. Biodivers.</source><year>2014</year><volume>11</volume><fpage>1374</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201300392</pub-id><pub-id pub-id-type="pmid">25238078</pub-id></element-citation></ref><ref id="B44-ijms-21-07078"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>J.D.</given-names></name><name><surname>Bagul</surname><given-names>S.D.</given-names></name><name><surname>Bendre</surname><given-names>R.S.</given-names></name></person-group><article-title>Design, synthesis, biological screenings and docking simulations of novel carvacrol and thymol derivatives containing acetohydrazone linkage</article-title><source>Res. Chem. Intermed.</source><year>2017</year><volume>43</volume><fpage>4893</fpage><lpage>4906</lpage><pub-id pub-id-type="doi">10.1007/s11164-017-2919-2</pub-id></element-citation></ref><ref id="B45-ijms-21-07078"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.Q.</given-names></name><name><surname>Sun</surname><given-names>Z.Y.</given-names></name><name><surname>Feng</surname><given-names>X.Y.</given-names></name><name><surname>Chen</surname><given-names>R.J.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>Y.L.</given-names></name><name><surname>Guo</surname><given-names>Z.Y.</given-names></name><name><surname>Liu</surname><given-names>C.X.</given-names></name><name><surname>Chen</surname><given-names>J.F.</given-names></name><name><surname>Zou</surname><given-names>K.</given-names></name></person-group><article-title>Thymol derivatives from the roots of <italic>Eupatorium chinense</italic> and their cytotoxic activities</article-title><source>Phytochem. Lett.</source><year>2019</year><volume>29</volume><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2018.12.008</pub-id></element-citation></ref><ref id="B46-ijms-21-07078"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group><article-title>New thymol and isothymol derivatives from <italic>Eupatorium fortunei</italic> and their cytotoxic effects</article-title><source>Bioorg. Chem.</source><year>2020</year><volume>98</volume><fpage>103644</fpage><lpage>103648</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2020.103644</pub-id><?supplied-pmid 32033791?><pub-id pub-id-type="pmid">32033791</pub-id></element-citation></ref><ref id="B47-ijms-21-07078"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.J.</given-names></name><name><surname>Tsai</surname><given-names>Y.C.</given-names></name><name><surname>Hwang</surname><given-names>T.L.</given-names></name><name><surname>Wang</surname><given-names>T.C.</given-names></name></person-group><article-title>Thymol, benzofuranoid, and phenylpropanoid derivatives: Anti-inflammatory constituents from <italic>Eupatorium cannabinum</italic></article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1021</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1021/np100923z</pub-id><pub-id pub-id-type="pmid">21391659</pub-id></element-citation></ref><ref id="B48-ijms-21-07078"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name></person-group><article-title>Chemical constituents from <italic>Inula wissmanniana</italic> and their anti-inflammatory activities</article-title><source>Arch. Pharm. Res.</source><year>2013</year><volume>36</volume><fpage>1516</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1007/s12272-013-0143-1</pub-id><pub-id pub-id-type="pmid">23703255</pub-id></element-citation></ref><ref id="B49-ijms-21-07078"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesterkina</surname><given-names>M.</given-names></name><name><surname>Kravchenko</surname><given-names>I.</given-names></name></person-group><article-title>Synthesis and pharmacological properties of novel esters based on monoterpenoids and glycine</article-title><source>Pharmaceuticals (Basel)</source><year>2017</year><volume>10</volume><elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.3390/ph10020047</pub-id></element-citation></ref><ref id="B50-ijms-21-07078"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesquita</surname><given-names>B.M.</given-names></name><name><surname>do Nascimento</surname><given-names>P.G.G.</given-names></name><name><surname>Souza</surname><given-names>L.G.S.</given-names></name><name><surname>de Farias</surname><given-names>I.F.</given-names></name><name><surname>da Silva</surname><given-names>R.A.C.</given-names></name><name><surname>de Lemos</surname><given-names>T.L.G.</given-names></name><name><surname>Monte</surname><given-names>F.J.Q.</given-names></name><name><surname>Oliveira</surname><given-names>I.R.</given-names></name><name><surname>Trevisan</surname><given-names>M.T.S.</given-names></name><name><surname>da Silva</surname><given-names>H.C.</given-names></name></person-group><article-title>Synthesis, larvicidal and acetylcholinesterase inhibitory activities of carvacrol/thymol and derivatives</article-title><source>Quim. Nova</source><year>2018</year><volume>41</volume><fpage>412</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.21577/0100-4042.20170189</pub-id></element-citation></ref><ref id="B51-ijms-21-07078"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt</surname><given-names>B.Z.</given-names></name><name><surname>Gazioglu</surname><given-names>I.</given-names></name><name><surname>Dag</surname><given-names>A.</given-names></name><name><surname>Salmas</surname><given-names>R.E.</given-names></name><name><surname>Kayik</surname><given-names>G.</given-names></name><name><surname>Durdagi</surname><given-names>S.</given-names></name><name><surname>Sonmez</surname><given-names>F.</given-names></name></person-group><article-title>Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol/carvacrol derivatives</article-title><source>Bioorg. Med. Chem.</source><year>2017</year><volume>25</volume><fpage>1352</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2016.12.037</pub-id><?supplied-pmid 28089589?><pub-id pub-id-type="pmid">28089589</pub-id></element-citation></ref><ref id="B52-ijms-21-07078"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>M.</given-names></name><name><surname>Genc</surname><given-names>H.</given-names></name><name><surname>Taslimi</surname><given-names>P.</given-names></name><name><surname>Kestane</surname><given-names>A.</given-names></name><name><surname>Guclu</surname><given-names>E.</given-names></name><name><surname>Ogutlu</surname><given-names>A.</given-names></name><name><surname>Karabay</surname><given-names>O.</given-names></name><name><surname>Gul&#x000e7;in</surname><given-names>I.</given-names></name></person-group><article-title>Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors&#x02014;Their antidiabetic, anticholinergic and antibacterial potentials</article-title><source>Bioorg. Chem.</source><year>2018</year><volume>81</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2018.08.003</pub-id><pub-id pub-id-type="pmid">30118983</pub-id></element-citation></ref><ref id="B53-ijms-21-07078"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brotzman</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Graybill</surname><given-names>A.</given-names></name><name><surname>Cocolas</surname><given-names>A.</given-names></name><name><surname>Ressler</surname><given-names>A.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Henry</surname><given-names>G.E.</given-names></name></person-group><article-title>Synthesis and tyrosinase inhibitory activities of 4-oxobutanoate derivatives of carvacrol and thymol</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2019</year><volume>29</volume><fpage>56</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2018.11.013</pub-id><?supplied-pmid 30446314?><pub-id pub-id-type="pmid">30446314</pub-id></element-citation></ref><ref id="B54-ijms-21-07078"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>J.G.</given-names></name><name><surname>Picard</surname><given-names>M.</given-names></name><name><surname>B&#x000e9;nard</surname><given-names>S.</given-names></name><name><surname>Desvignes</surname><given-names>C.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>Diotel</surname><given-names>N.</given-names></name><name><surname>El Kalamouni</surname><given-names>C.</given-names></name></person-group><article-title><italic>Ayapana triplinervis</italic> essential oil and its main component thymohydroquinone dimethyl ether inhibit Zika virus at doses devoid of toxicity in zebrafish</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3447</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24193447</pub-id><?supplied-pmid 31547527?><pub-id pub-id-type="pmid">31547527</pub-id></element-citation></ref><ref id="B55-ijms-21-07078"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latacz</surname><given-names>G.</given-names></name><name><surname>Lubelska</surname><given-names>A.</given-names></name><name><surname>Jastrz&#x00119;bska-Wi&#x00119;sek</surname><given-names>M.</given-names></name><name><surname>Partyka</surname><given-names>A.</given-names></name><name><surname>Mar&#x00107;</surname><given-names>M.A.</given-names></name><name><surname>Sata&#x00142;a</surname><given-names>G.</given-names></name><name><surname>Wilczy&#x00144;ska</surname><given-names>D.</given-names></name><name><surname>Kota&#x00144;ska</surname><given-names>M.</given-names></name><name><surname>Wi&#x00119;cek</surname><given-names>M.</given-names></name><name><surname>Kami&#x00144;ska</surname><given-names>K.</given-names></name><etal/></person-group><article-title>The 1,3,5-triazine derivatives as innovative chemical family of 5-HT6 serotonin receptor agents with therapeutic perspectives for cognitive impairment</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>3420</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20143420</pub-id></element-citation></ref><ref id="B56-ijms-21-07078"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindmark-Henriksson</surname><given-names>M.</given-names></name><name><surname>Isaksson</surname><given-names>D.</given-names></name><name><surname>Van&#x0011b;k</surname><given-names>T.</given-names></name><name><surname>Valterov&#x000e1;</surname><given-names>I.</given-names></name><name><surname>H&#x000f6;gberg</surname><given-names>H.E.</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>K.</given-names></name></person-group><article-title>Transformation of terpenes using a Picea abies suspension culture</article-title><source>J. Biotechnol.</source><year>2004</year><volume>107</volume><fpage>173</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2003.10.009</pub-id><pub-id pub-id-type="pmid">14711500</pub-id></element-citation></ref><ref id="B57-ijms-21-07078"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>L.H.</given-names></name><name><surname>Perumal</surname><given-names>S.</given-names></name><name><surname>Balasubramanian</surname><given-names>M.P.</given-names></name></person-group><article-title>Myrtenal, a natural monoterpene, down-regulates TNF-a expression and suppresses carcinogeninduced hepatocellular carcinoma in rats</article-title><source>Mol. Cell. Biochem.</source><year>2012</year><volume>369</volume><fpage>183</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1007/s11010-012-1381-0</pub-id><pub-id pub-id-type="pmid">22763672</pub-id></element-citation></ref><ref id="B58-ijms-21-07078"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingaiah</surname><given-names>H.B.</given-names></name><name><surname>Srinivasan</surname><given-names>P.</given-names></name><name><surname>Periyasamy</surname><given-names>B.M.</given-names></name></person-group><article-title>Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades</article-title><source>Cell. Oncol.</source><year>2012</year><volume>35</volume><fpage>269</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1007/s13402-012-0086-4</pub-id></element-citation></ref><ref id="B59-ijms-21-07078"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>A.</given-names></name><name><surname>Pari</surname><given-names>L.</given-names></name><name><surname>Chandramohan</surname><given-names>R.</given-names></name><name><surname>Sheikh</surname><given-names>B.A.</given-names></name></person-group><article-title>Histopathological findings of the pancreas, liver, and carbohydrate metabolizing enzymes in STZ-induced diabetic rats improved by administration of myrtenal</article-title><source>J. Physiol. Biochem.</source><year>2014</year><volume>70</volume><fpage>935</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1007/s13105-014-0362-z</pub-id><pub-id pub-id-type="pmid">25292424</pub-id></element-citation></ref><ref id="B60-ijms-21-07078"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trytek</surname><given-names>M.</given-names></name><name><surname>Paduch</surname><given-names>R.</given-names></name><name><surname>Piet</surname><given-names>M.</given-names></name><name><surname>Koziel</surname><given-names>A.</given-names></name><name><surname>Kandefer-Szerszen</surname><given-names>M.</given-names></name><name><surname>Szajnecki</surname><given-names>&#x00141;.</given-names></name><name><surname>Gromada</surname><given-names>A.</given-names></name></person-group><article-title>Biological activity of oxygenated pinene derivatives on human colon normal and carcinoma cells</article-title><source>Flavour Frag. J.</source><year>2018</year><volume>33</volume><fpage>428</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1002/ffj.3471</pub-id></element-citation></ref><ref id="B61-ijms-21-07078"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbuceanu</surname><given-names>S.F.</given-names></name><name><surname>Saramet</surname><given-names>G.</given-names></name><name><surname>Almajan</surname><given-names>G.L.</given-names></name><name><surname>Draghici</surname><given-names>C.</given-names></name><name><surname>Barbuceanu</surname><given-names>F.</given-names></name><name><surname>Bancescu</surname><given-names>G.</given-names></name></person-group><article-title>New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation</article-title><source>Eur. J. Med. Chem.</source><year>2012</year><volume>49</volume><fpage>417</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2012.01.031</pub-id><pub-id pub-id-type="pmid">22309915</pub-id></element-citation></ref><ref id="B62-ijms-21-07078"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzgoren-Baran</surname><given-names>A.</given-names></name><name><surname>Tel</surname><given-names>B.C.</given-names></name><name><surname>Sarigol</surname><given-names>D.</given-names></name><name><surname>Ozturk</surname><given-names>E.I.</given-names></name><name><surname>Kazkayasi</surname><given-names>I.</given-names></name><name><surname>Okay</surname><given-names>G.</given-names></name><name><surname>Ertan</surname><given-names>M.</given-names></name><name><surname>Tozkoparan</surname><given-names>B.</given-names></name></person-group><article-title>Thiazolo[3,2-b]-1,2,4-triazole-5(6H)-one substituted with ibuprofen: Novel non-steroidal anti-inflammatory agents with favorable gastrointestinal tolerance</article-title><source>Eur. J. Med. Chem.</source><year>2012</year><volume>57</volume><fpage>398</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2012.07.009</pub-id><?supplied-pmid 22840494?><pub-id pub-id-type="pmid">22840494</pub-id></element-citation></ref><ref id="B63-ijms-21-07078"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.H.</given-names></name><name><surname>Xu</surname><given-names>X.Y.</given-names></name><name><surname>Tan</surname><given-names>C.X.</given-names></name><name><surname>Weng</surname><given-names>J.Q.</given-names></name><name><surname>Xin</surname><given-names>J.H.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Synthesis, crystal structure, herbicidal activities and 3D-QSAR study of some novel 1,2,4-triazolo[4,3-a]pyridine derivatives</article-title><source>Pest. Manag. Sci.</source><year>2015</year><volume>71</volume><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1002/ps.3804</pub-id><?supplied-pmid 24753294?><pub-id pub-id-type="pmid">24753294</pub-id></element-citation></ref><ref id="B64-ijms-21-07078"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G.S.</given-names></name><name><surname>Duan</surname><given-names>W.G.</given-names></name><name><surname>Yang</surname><given-names>L.X.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Lei</surname><given-names>F.H.</given-names></name></person-group><article-title>Synthesis and antifungal activity of novel myrtenal-based 4-methyl-1,2,4-triazole-thioethers</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>193</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020193</pub-id></element-citation></ref><ref id="B65-ijms-21-07078"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Lei</surname><given-names>F.</given-names></name></person-group><article-title>Synthesis and biological activity of novel myrtenal-derived 2-acyl-1,2,4-triazole-3-thione compounds</article-title><source>Chin. J. Org. Chem.</source><year>2018</year><volume>38</volume><fpage>2085</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.6023/cjoc201801043</pub-id></element-citation></ref><ref id="B66-ijms-21-07078"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanka</surname><given-names>L.</given-names></name><name><surname>Iqbal</surname><given-names>K.</given-names></name><name><surname>Schreiner</surname><given-names>P.R.</given-names></name></person-group><article-title>The lipophilic bullet hits the targets: Medicinal chemistry of adamantane derivatives</article-title><source>Chem. Rev.</source><year>2013</year><volume>113</volume><fpage>3516</fpage><lpage>3604</lpage><pub-id pub-id-type="doi">10.1021/cr100264t</pub-id><?supplied-pmid 23432396?><pub-id pub-id-type="pmid">23432396</pub-id></element-citation></ref><ref id="B67-ijms-21-07078"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapitsa</surname><given-names>I.G.</given-names></name><name><surname>Suslov</surname><given-names>E.V.</given-names></name><name><surname>Teplov</surname><given-names>G.V.</given-names></name><name><surname>Korchagina</surname><given-names>D.V.</given-names></name><name><surname>Komarova</surname><given-names>N.I.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><name><surname>Voronina</surname><given-names>T.A.</given-names></name><name><surname>Shevela</surname><given-names>A.I.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Search for new drugs. Synthesis and anxiolytic activity of 2-aminoadamantane derivatives containing monoterpene fragments</article-title><source>Pharm. Chem. J.</source><year>2012</year><volume>46</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1007/s11094-012-0775-3</pub-id></element-citation></ref><ref id="B68-ijms-21-07078"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teplov</surname><given-names>G.V.</given-names></name><name><surname>Suslov</surname><given-names>E.V.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Karpinskaya</surname><given-names>L.A.</given-names></name><name><surname>Rogachev</surname><given-names>A.D.</given-names></name><name><surname>Korchagina</surname><given-names>D.V.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name><name><surname>Kiselev</surname><given-names>O.I.</given-names></name></person-group><article-title>Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A(H1N1)pdm09</article-title><source>Lett. Drug Des. Discov.</source><year>2013</year><volume>10</volume><fpage>477</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.2174/1570180811310060002</pub-id></element-citation></ref><ref id="B69-ijms-21-07078"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suslov</surname><given-names>E.V.</given-names></name><name><surname>Ponomarev</surname><given-names>K.Y.</given-names></name><name><surname>Rogachev</surname><given-names>A.D.</given-names></name><name><surname>Pokrovsky</surname><given-names>M.A.</given-names></name><name><surname>Pokrovsky</surname><given-names>A.G.</given-names></name><name><surname>Pykhtina</surname><given-names>M.B.</given-names></name><name><surname>Beklemishev</surname><given-names>A.B.</given-names></name><name><surname>Korchagina</surname><given-names>D.V.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Compounds combining aminoadamantane and monoterpene moieties: Cytotoxicity and mutagenic effects</article-title><source>Med. Chem.</source><year>2015</year><volume>11</volume><fpage>629</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.2174/1573406411666150518110053</pub-id><pub-id pub-id-type="pmid">25981517</pub-id></element-citation></ref><ref id="B70-ijms-21-07078"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponomarev</surname><given-names>K.Y.</given-names></name><name><surname>Suslov</surname><given-names>E.V.</given-names></name><name><surname>Zakharenko</surname><given-names>A.L.</given-names></name><name><surname>Zakharova</surname><given-names>O.D.</given-names></name><name><surname>Rogachev</surname><given-names>A.D.</given-names></name><name><surname>Korchagina</surname><given-names>D.V.</given-names></name><name><surname>Zafar</surname><given-names>A.</given-names></name><name><surname>Reynisson</surname><given-names>J.</given-names></name><name><surname>Nefedov</surname><given-names>A.A.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><etal/></person-group><article-title>Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors</article-title><source>Bioorg. Chem.</source><year>2018</year><volume>76</volume><fpage>392</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2017.12.005</pub-id><pub-id pub-id-type="pmid">29248742</pub-id></element-citation></ref><ref id="B71-ijms-21-07078"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponomarev</surname><given-names>K.Y.</given-names></name><name><surname>Morozova</surname><given-names>E.A.</given-names></name><name><surname>Suslov</surname><given-names>E.V.</given-names></name><name><surname>Korchagina</surname><given-names>D.V.</given-names></name><name><surname>Tolstikova</surname><given-names>T.G.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Synthesis and analgesic activity of 5,7- and 6-substituted diazaadamantanes containing monoterpene moieties</article-title><source>Chem. Nat. Compd.</source><year>2017</year><volume>53</volume><fpage>1131</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1007/s10600-017-2216-8</pub-id></element-citation></ref><ref id="B72-ijms-21-07078"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonda</surname><given-names>T.</given-names></name><name><surname>B&#x000e9;rdi</surname><given-names>P.</given-names></name><name><surname>Zupk&#x000f3;</surname><given-names>I.</given-names></name><name><surname>F&#x000fc;l&#x000f6;p</surname><given-names>F.</given-names></name><name><surname>Szakonyi</surname><given-names>Z.</given-names></name></person-group><article-title>Stereoselective synthesis, synthetic and pharmacological application of monoterpene-based 1,2,4- and 1,3,4-oxadiazoles</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>81</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19010081</pub-id><?supplied-pmid 29283373?><pub-id pub-id-type="pmid">29283373</pub-id></element-citation></ref><ref id="B73-ijms-21-07078"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitina</surname><given-names>L.E.</given-names></name><name><surname>Startseva</surname><given-names>V.A.</given-names></name><name><surname>Vakulenko</surname><given-names>I.A.</given-names></name><name><surname>Khismatulina</surname><given-names>I.M.</given-names></name><name><surname>Lisovskaya</surname><given-names>S.A.</given-names></name><name><surname>Glushko</surname><given-names>N.P.</given-names></name><name><surname>Fassakhov</surname><given-names>R.S.</given-names></name></person-group><article-title>Synthesis and antifungal activity of compounds of the pinane series</article-title><source>Pharm. Chem. J.</source><year>2009</year><volume>43</volume><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1007/s11094-009-0282-3</pub-id></element-citation></ref><ref id="B74-ijms-21-07078"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>A.C.R.</given-names></name><name><surname>Lopes</surname><given-names>P.M.</given-names></name><name><surname>Azevedo</surname><given-names>M.M.B.</given-names></name><name><surname>Costa</surname><given-names>D.C.M.</given-names></name><name><surname>Alviano</surname><given-names>C.S.</given-names></name><name><surname>Alviano</surname><given-names>D.S.</given-names></name></person-group><article-title>Biological activities of <italic>&#x003b1;</italic>-pinene and <italic>&#x003b2;</italic>-pinene enantiomers</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>6305</fpage><lpage>6316</lpage><pub-id pub-id-type="doi">10.3390/molecules17066305</pub-id><pub-id pub-id-type="pmid">22634841</pub-id></element-citation></ref><ref id="B75-ijms-21-07078"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felipe</surname><given-names>C.F.B.</given-names></name><name><surname>Albuquerque</surname><given-names>A.M.S.</given-names></name><name><surname>de Pontes</surname><given-names>J.L.X.</given-names></name><name><surname>de Melo</surname><given-names>J.V.</given-names></name><name><surname>Rodrigues</surname><given-names>T.C.M.L.</given-names></name><name><surname>de Sousa</surname><given-names>A.M.P.</given-names></name><name><surname>Monteiro</surname><given-names>A.B.</given-names></name><name><surname>da Silva Ribeiro</surname><given-names>A.E.</given-names></name><name><surname>Lopes</surname><given-names>J.P.</given-names></name><name><surname>Menezes</surname><given-names>I.R.A.</given-names></name><etal/></person-group><article-title>Comparative study of alpha- and beta-pinene effect on PTZ-induced convulsions in mice</article-title><source>Fund. Clin. Pharmacol.</source><year>2019</year><volume>33</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/fcp.12416</pub-id></element-citation></ref><ref id="B76-ijms-21-07078"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Upadhyay</surname><given-names>S.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Jugran</surname><given-names>A.K.</given-names></name><name><surname>Jayaweera</surname><given-names>S.L.D.</given-names></name><name><surname>Dias</surname><given-names>D.A.</given-names></name><name><surname>Sharopov</surname><given-names>F.</given-names></name><name><surname>Taheri</surname><given-names>Y.</given-names></name><name><surname>Martins</surname><given-names>N.</given-names></name><name><surname>Baghalpour</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Therapeutic potential of <italic>&#x003b1;</italic>- and <italic>&#x003b2;</italic>-pinene: A miracle gift of nature</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><elocation-id>738</elocation-id><pub-id pub-id-type="doi">10.3390/biom9110738</pub-id></element-citation></ref><ref id="B77-ijms-21-07078"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>S.</given-names></name><name><surname>Shang</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>M.</given-names></name><name><surname>Xiaoping Rao</surname><given-names>X.</given-names></name><name><surname>Si</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><article-title>One-pot synthesis and antimicrobial evaluation of novel 3-cyanopyridine derivatives of (&#x02013;)-<italic>&#x003b2;</italic>-pinene</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>1512</fpage><lpage>1515</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.02.024</pub-id><pub-id pub-id-type="pmid">26898336</pub-id></element-citation></ref><ref id="B78-ijms-21-07078"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Si</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>Z.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Hydronopylformamides: Modification of the naturally occurring compound (&#x02013;)-<italic>&#x003b2;</italic>-pinene to produce insect repellent candidates against <italic>Blattella germanica</italic></article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1004</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22061004</pub-id></element-citation></ref><ref id="B79-ijms-21-07078"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitina</surname><given-names>L.E.</given-names></name><name><surname>Kiselev</surname><given-names>S.V.</given-names></name><name><surname>Startseva</surname><given-names>V.A.</given-names></name><name><surname>Lodochnikova</surname><given-names>O.A.</given-names></name><name><surname>Rakhmatullina</surname><given-names>A.A.</given-names></name><name><surname>Fedyunina</surname><given-names>I.V.</given-names></name><name><surname>Gilfanova</surname><given-names>I.R.</given-names></name></person-group><article-title>New aspects of using biologically active thioterpenoids of pinane series</article-title><source>Russ. Chem. Bull. Int. Ed.</source><year>2019</year><volume>68</volume><fpage>1031</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1007/s11172-019-2515-2</pub-id></element-citation></ref><ref id="B80-ijms-21-07078"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Anti-tumor activities and mechanism study of <italic>&#x003b1;</italic>-pinene derivative in vivo and in vitro</article-title><source>Cancer Chemoth. Pharm.</source><year>2020</year><volume>85</volume><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1007/s00280-019-03997-x</pub-id></element-citation></ref><ref id="B81-ijms-21-07078"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Shan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Kuang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Design, synthesis and anticancer activity of novel nopinone-based thiosemicarbazone derivatives</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2017</year><volume>27</volume><fpage>2360</fpage><lpage>2363</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.04.024</pub-id><?supplied-pmid 28431878?><pub-id pub-id-type="pmid">28431878</pub-id></element-citation></ref><ref id="B82-ijms-21-07078"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Shan</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>Design, synthesis and biological evaluation of novel <italic>&#x003b2;</italic>-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway</article-title><source>Bioorg. Chem.</source><year>2019</year><volume>84</volume><fpage>468</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2018.12.010</pub-id><pub-id pub-id-type="pmid">30576910</pub-id></element-citation></ref><ref id="B83-ijms-21-07078"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obieziurska</surname><given-names>M.</given-names></name><name><surname>Pacu&#x00142;a</surname><given-names>A.J.</given-names></name><name><surname>D&#x00142;ugosz-Pokorska</surname><given-names>A.</given-names></name><name><surname>Krzemi&#x00144;ski</surname><given-names>M.</given-names></name><name><surname>Janecka</surname><given-names>A.</given-names></name><name><surname>&#x0015a;cianowski</surname><given-names>J.</given-names></name></person-group><article-title>Bioselectivity induced by chirality of new terpenyl organoselenium compounds</article-title><source>Materials</source><year>2019</year><volume>12</volume><elocation-id>3579</elocation-id><pub-id pub-id-type="doi">10.3390/ma12213579</pub-id></element-citation></ref><ref id="B84-ijms-21-07078"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G.S.</given-names></name><name><surname>Ma</surname><given-names>C.H.</given-names></name><name><surname>Duan</surname><given-names>W.G.</given-names></name><name><surname>Cen</surname><given-names>B.</given-names></name><name><surname>Lei</surname><given-names>F.H.</given-names></name><name><surname>Yang</surname><given-names>Z.Q.</given-names></name></person-group><article-title>Synthesis and biological activities of <italic>&#x003b1;</italic>-pinene-based dithiadiazoles</article-title><source>Holzforschung</source><year>2014</year><volume>68</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1515/hf-2013-0006</pub-id></element-citation></ref><ref id="B85-ijms-21-07078"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Hyun</surname><given-names>E.A.</given-names></name><name><surname>Yoon</surname><given-names>W.J.</given-names></name><name><surname>Kim</surname><given-names>B.H.</given-names></name><name><surname>Rhee</surname><given-names>M.H.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name><name><surname>Yoo</surname><given-names>E.S.</given-names></name></person-group><article-title>In vitro anti-inflammatory and anti-oxidative effects of <italic>Cinnamomum camphora</italic> extracts</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>103</volume><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.08.009</pub-id><?supplied-pmid 16182479?><pub-id pub-id-type="pmid">16182479</pub-id></element-citation></ref><ref id="B86-ijms-21-07078"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Vermaak</surname><given-names>I.</given-names></name><name><surname>Viljoen</surname><given-names>A.</given-names></name></person-group><article-title>Camphor&#x02014;A fumigant during the black death and a coveted fragrant wood in ancient Egypt and Babylon&#x02014;A Review</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>5434</fpage><lpage>5454</lpage><pub-id pub-id-type="doi">10.3390/molecules18055434</pub-id><pub-id pub-id-type="pmid">23666009</pub-id></element-citation></ref><ref id="B87-ijms-21-07078"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Geng</surname><given-names>Z.</given-names></name><name><surname>Du</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name></person-group><article-title>Identification of repellent and insecticidal constituents from <italic>Artemisia mongolica</italic> essential oil against <italic>Lasioderma Serricorne</italic></article-title><source>J. Chem.</source><year>2015</year><volume>2015</volume><fpage>549057</fpage><pub-id pub-id-type="doi">10.1155/2015/549057</pub-id></element-citation></ref><ref id="B88-ijms-21-07078"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Shernyukov</surname><given-names>A.V.</given-names></name><name><surname>Gatilov</surname><given-names>Y.V.</given-names></name><name><surname>Razumova</surname><given-names>Y.V.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Tretiak</surname><given-names>T.S.</given-names></name><name><surname>Pokrovsky</surname><given-names>A.G.</given-names></name><name><surname>Kiselev</surname><given-names>O.I.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Discovery of a new class of antiviral compounds: Camphor imine derivatives</article-title><source>Eur. J. Med. Chem.</source><year>2015</year><volume>105</volume><fpage>263</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2015.10.010</pub-id><pub-id pub-id-type="pmid">26498572</pub-id></element-citation></ref><ref id="B89-ijms-21-07078"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name></person-group><article-title>Terpenes: The expansion of chiral pool</article-title><source>Handbook of Chiral Chemicals</source><edition>2nd ed.</edition><person-group person-group-type="editor"><name><surname>Ager</surname><given-names>D.J.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2005</year><fpage>59</fpage><lpage>74</lpage></element-citation></ref><ref id="B90-ijms-21-07078"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name><name><surname>Volcho</surname><given-names>K.P.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name></person-group><article-title>Monoterpenes as a renewable source of biologically active compounds</article-title><source>Pure Appl. Chem.</source><year>2017</year><volume>898</volume><fpage>1105</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1515/pac-2017-0109</pub-id></element-citation></ref><ref id="B91-ijms-21-07078"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Mainagashev</surname><given-names>I.Y.</given-names></name><name><surname>Volobueva</surname><given-names>A.S.</given-names></name><name><surname>Lantseva</surname><given-names>K.</given-names></name><name><surname>Borisevich</surname><given-names>S.S.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2019</year><volume>29</volume><fpage>126745</fpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2019.126745</pub-id><?supplied-pmid 31668423?><pub-id pub-id-type="pmid">31668423</pub-id></element-citation></ref><ref id="B92-ijms-21-07078"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Pushkina</surname><given-names>E.A.</given-names></name><name><surname>Borisevich</surname><given-names>S.S.</given-names></name><name><surname>Galochkina</surname><given-names>A.V.</given-names></name><name><surname>Garshinina</surname><given-names>A.V.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Egorova</surname><given-names>A.A.</given-names></name><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Khursan</surname><given-names>S.L.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><etal/></person-group><article-title>Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity</article-title><source>Virology</source><year>2018</year><volume>524</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2018.08.011</pub-id><pub-id pub-id-type="pmid">30165308</pub-id></element-citation></ref><ref id="B93-ijms-21-07078"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Shernyukov</surname><given-names>A.V.</given-names></name><name><surname>Pokrovsky</surname><given-names>M.A.</given-names></name><name><surname>Pokrovsky</surname><given-names>A.G.</given-names></name><name><surname>Lavrinenko</surname><given-names>V.A.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Tretiak</surname><given-names>T.S.</given-names></name><name><surname>Anfimov</surname><given-names>P.M.</given-names></name><name><surname>Kiselev</surname><given-names>O.I.</given-names></name><etal/></person-group><article-title>New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity</article-title><source>Bioorg. Med. Chem.</source><year>2013</year><volume>21</volume><fpage>6690</fpage><lpage>6698</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2013.08.014</pub-id><?supplied-pmid 23993669?><pub-id pub-id-type="pmid">23993669</pub-id></element-citation></ref><ref id="B94-ijms-21-07078"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Baev</surname><given-names>D.S.</given-names></name><name><surname>Shernyukov</surname><given-names>A.V.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1</article-title><source>Eur. J. Med. Chem.</source><year>2017</year><volume>127</volume><fpage>661</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2016.10.035</pub-id><?supplied-pmid 27823881?><pub-id pub-id-type="pmid">27823881</pub-id></element-citation></ref><ref id="B95-ijms-21-07078"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>E.T.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>A.S.</given-names></name><name><surname>Moraes</surname><given-names>A.M.</given-names></name><name><surname>Souza</surname><given-names>L.A.</given-names></name><name><surname>Louren&#x000e7;o</surname><given-names>M.C.S.</given-names></name><name><surname>Souza</surname><given-names>M.V.N.</given-names></name><name><surname>Wardell</surname><given-names>J.L.</given-names></name><name><surname>Wardell</surname><given-names>S.M.S.V.</given-names></name></person-group><article-title>Synthesis and biological activities of camphor hydrazone and imine derivatives</article-title><source>Sci. Pharm.</source><year>2016</year><volume>84</volume><elocation-id>467</elocation-id><pub-id pub-id-type="doi">10.3390/scipharm84030467</pub-id></element-citation></ref><ref id="B96-ijms-21-07078"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovaleva</surname><given-names>K.S.</given-names></name><name><surname>Zubkov</surname><given-names>F.I.</given-names></name><name><surname>Bormotov</surname><given-names>N.I.</given-names></name><name><surname>Novikov</surname><given-names>R.A.</given-names></name><name><surname>Dorovatovskii</surname><given-names>P.V.</given-names></name><name><surname>Khrustalev</surname><given-names>V.N.</given-names></name><name><surname>Gatilov</surname><given-names>Y.V.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Shishkinad</surname><given-names>L.N.</given-names></name><etal/></person-group><article-title>Synthesis of D-(+)-camphor-based <italic>N</italic>-acylhydrazones and their antiviral activity</article-title><source>Med. Chem. Commun.</source><year>2018</year><volume>9</volume><fpage>2072</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1039/C8MD00442K</pub-id></element-citation></ref><ref id="B97-ijms-21-07078"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.</given-names></name><name><surname>Pavlova</surname><given-names>A.</given-names></name><name><surname>Komarova</surname><given-names>N.</given-names></name><name><surname>Ardashov</surname><given-names>O.</given-names></name><name><surname>Shernyukov</surname><given-names>A.</given-names></name><name><surname>Gatilov</surname><given-names>Y.</given-names></name><name><surname>Yarovaya</surname><given-names>O.</given-names></name><name><surname>Tolstikova</surname><given-names>T.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.</given-names></name></person-group><article-title>Synthesis and analgesic activity of new <italic>&#x003b1;</italic>-truxillic acid derivatives with monoterpenoid fragments</article-title><source>Med. Chem. Res.</source><year>2016</year><volume>25</volume><fpage>1608</fpage><lpage>1615</lpage><pub-id pub-id-type="doi">10.1007/s00044-016-1593-z</pub-id></element-citation></ref><ref id="B98-ijms-21-07078"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Bormotov</surname><given-names>N.I.</given-names></name><name><surname>Shishkina</surname><given-names>L.N.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Discovery of a new class of inhibitors of Vaccinia Virus based on (&#x02013;)-borneol from <italic>Abies sibirica</italic> and (+)-camphor</article-title><source>Chem. Biodivers.</source><year>2018</year><volume>15</volume><fpage>e1800153</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201800153</pub-id><?supplied-pmid 29956885?><pub-id pub-id-type="pmid">29956885</pub-id></element-citation></ref><ref id="B99-ijms-21-07078"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artyushin</surname><given-names>O.I.</given-names></name><name><surname>Moiseeva</surname><given-names>A.A.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Slita</surname><given-names>A.V.</given-names></name><name><surname>Galochkina</surname><given-names>A.V.</given-names></name><name><surname>Muryleva</surname><given-names>A.A.</given-names></name><name><surname>Borisevich</surname><given-names>S.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name><name><surname>Brel</surname><given-names>V.K.</given-names></name></person-group><article-title>Synthesis of camphecene and cytisine conjugates using click chemistry methodology and study of their antiviral activity</article-title><source>Chem. Biodivers.</source><year>2019</year><volume>16</volume><fpage>e1900340</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201900340</pub-id><pub-id pub-id-type="pmid">31647170</pub-id></element-citation></ref><ref id="B100-ijms-21-07078"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyshov</surname><given-names>V.V.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Fadeev</surname><given-names>D.S.</given-names></name><name><surname>Gatilov</surname><given-names>Y.V.</given-names></name><name><surname>Esaulkova</surname><given-names>Y.L.</given-names></name><name><surname>Muryleva</surname><given-names>A.S.</given-names></name><name><surname>Sinegubova</surname><given-names>K.O.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Single-stage synthesis of heterocyclic alkaloid-like compounds from (+)-camphoric acid and their antiviral activity</article-title><source>Mol. Divers.</source><year>2020</year><volume>24</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s11030-019-09932-9</pub-id><pub-id pub-id-type="pmid">30820742</pub-id></element-citation></ref><ref id="B101-ijms-21-07078"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikl&#x000e1;&#x00161;</surname><given-names>R.</given-names></name><name><surname>Mikl&#x000e1;&#x00161;ov&#x000e1;</surname><given-names>N.</given-names></name><name><surname>Bukovsk&#x000fd;</surname><given-names>M.</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>B.</given-names></name><name><surname>Kubincov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Dev&#x000ed;nsky</surname><given-names>F.</given-names></name></person-group><article-title>Synthesis, surface and antimicrobial properties of some quaternary ammonium homochiral camphor sulphonamides</article-title><source>Eur. J. Pharm. Sci.</source><year>2014</year><volume>65</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2014.08.013</pub-id><pub-id pub-id-type="pmid">25218991</pub-id></element-citation></ref><ref id="B102-ijms-21-07078"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Baranova</surname><given-names>D.V.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Baev</surname><given-names>D.S.</given-names></name><name><surname>Polezhaeva</surname><given-names>O.A.</given-names></name><name><surname>Zybkina</surname><given-names>A.V.</given-names></name><name><surname>Shcherbakov</surname><given-names>D.N.</given-names></name><name><surname>Tolstikova</surname><given-names>T.G.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Synthesis of (1<italic>S</italic>)-(+)-camphor-10-sulfonic acid derivatives and investigations in vitro and in silico of their antiviral activity as the inhibitors of fi filovirus infections</article-title><source>Russ. Chem. Bull.</source><year>2019</year><volume>68</volume><fpage>1041</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1007/s11172-019-2517-0</pub-id></element-citation></ref><ref id="B103-ijms-21-07078"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>B.</given-names></name><name><surname>Luan</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Borneol-grafted cellulose for antifungal adhesion and fungal growth inhibition</article-title><source>RSC Adv.</source><year>2015</year><volume>5</volume><fpage>51947</fpage><lpage>51952</lpage><pub-id pub-id-type="doi">10.1039/C5RA07894F</pub-id></element-citation></ref><ref id="B104-ijms-21-07078"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>R.M.C.</given-names></name><name><surname>Leite</surname><given-names>F.C.</given-names></name><name><surname>Leite</surname><given-names>J.A.</given-names></name><name><surname>Mascarenhas</surname><given-names>S.R.</given-names></name><name><surname>Rodrigues</surname><given-names>L.C.</given-names></name><name><surname>Piuvezam</surname><given-names>M.R.</given-names></name></person-group><article-title>Synthesis, acute toxicity and anti-inflammatory effect of bornyl salicylate, a salicylic acid derivative</article-title><source>Immunopharm. Immunot.</source><year>2012</year><volume>34</volume><fpage>1028</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.3109/08923973.2012.694891</pub-id><?supplied-pmid 22712758?><pub-id pub-id-type="pmid">22712758</pub-id></element-citation></ref><ref id="B105-ijms-21-07078"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Borisova</surname><given-names>M.S.</given-names></name><name><surname>Morozova</surname><given-names>E.A.</given-names></name><name><surname>Tolstikova</surname><given-names>T.G.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Synthesis and biological activity of heterocyclic borneol derivatives</article-title><source>Chem. Heterocycl. Com.</source><year>2017</year><volume>53</volume><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1007/s10593-017-2063-3</pub-id></element-citation></ref><ref id="B106-ijms-21-07078"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Tao</surname><given-names>C.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration</article-title><source>Eur. J. Pharm. Sci.</source><year>2016</year><volume>88</volume><fpage>178</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2016.02.015</pub-id><pub-id pub-id-type="pmid">26965003</pub-id></element-citation></ref><ref id="B107-ijms-21-07078"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corr&#x000ea;a</surname><given-names>P.R.C.</given-names></name><name><surname>Miranda</surname><given-names>R.R.S.</given-names></name><name><surname>Duarte</surname><given-names>L.P.</given-names></name><name><surname>Silva</surname><given-names>G.D.F.</given-names></name><name><surname>Filho</surname><given-names>S.A.</given-names></name><name><surname>Okuma</surname><given-names>A.A.</given-names></name><name><surname>Carazza</surname><given-names>F.</given-names></name><name><surname>Morgado-D&#x000ed;az</surname><given-names>J.A.</given-names></name><name><surname>Pinge-Filho</surname><given-names>P.</given-names></name><name><surname>Yamauchi</surname><given-names>L.M.</given-names></name><etal/></person-group><article-title>Antimicrobial activity of synthetic bornyl benzoates against <italic>Trypanosoma cruzi</italic></article-title><source>Pathog. Glob. Health.</source><year>2012</year><volume>106</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1179/2047773212Y.0000000002</pub-id><pub-id pub-id-type="pmid">22943546</pub-id></element-citation></ref><ref id="B108-ijms-21-07078"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>A.T.M.</given-names></name><name><surname>Pereira</surname><given-names>V.V.</given-names></name><name><surname>de Almeida</surname><given-names>L.T.G.</given-names></name><name><surname>Ruiz</surname><given-names>A.L.T.G.</given-names></name><name><surname>de Carvalho</surname><given-names>J.E.</given-names></name><name><surname>Dias</surname><given-names>D.F.</given-names></name><name><surname>de Moreira</surname><given-names>M.E.C.</given-names></name><name><surname>Silva</surname><given-names>R.R.</given-names></name><name><surname>Duarte</surname><given-names>L.P.</given-names></name></person-group><article-title>Synthesis and biological activity of borneol esters</article-title><source>Rev. Virtual Quim.</source><year>2016</year><volume>8</volume><fpage>1020</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.5935/1984-6835.20160073</pub-id></element-citation></ref><ref id="B109-ijms-21-07078"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>A.T.M.</given-names></name><name><surname>Pereira</surname><given-names>V.V.</given-names></name><name><surname>Takahashi</surname><given-names>J.A.</given-names></name><name><surname>Silva</surname><given-names>R.R.</given-names></name><name><surname>Duarte</surname><given-names>L.P.</given-names></name></person-group><article-title>Microwave-assisted synthesis of borneol esters and their antimicrobial activity</article-title><source>Nat. Prod. Res.</source><year>2018</year><volume>32</volume><fpage>1714</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1399380</pub-id><pub-id pub-id-type="pmid">29124957</pub-id></element-citation></ref><ref id="B110-ijms-21-07078"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Setzer</surname><given-names>M.C.</given-names></name><name><surname>Bates</surname><given-names>R.B.</given-names></name><name><surname>Nakkiew</surname><given-names>P.</given-names></name><name><surname>Jackes</surname><given-names>B.R.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>McFerrin</surname><given-names>M.B.</given-names></name><name><surname>Meehan</surname><given-names>E.J.</given-names></name></person-group><article-title>Antibacterial hydroxycinnamic esters from <italic>Piper caninum</italic> from Paluma; North Queensland; Australia. The crystal and molecular structure of (+)-bornyl coumarate</article-title><source>Planta Med.</source><year>1999</year><volume>65</volume><fpage>747</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1055/s-2006-960855</pub-id><pub-id pub-id-type="pmid">10630119</pub-id></element-citation></ref><ref id="B111-ijms-21-07078"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>A.</given-names></name><name><surname>Ganguly</surname><given-names>S.</given-names></name><name><surname>Surana</surname><given-names>S.</given-names></name></person-group><article-title>A systematic review of benzimidazole derivatives as an antiulcer agent</article-title><source>Rasayan J. Chem.</source><year>2008</year><volume>1</volume><fpage>447</fpage><lpage>460</lpage></element-citation></ref><ref id="B112-ijms-21-07078"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naga</surname><given-names>P.K.</given-names></name><name><surname>Kumar</surname><given-names>K.R.</given-names></name></person-group><article-title>Green synthesis of benzimidazole derivatives: An overview of bulk drug synthesis</article-title><source>Int. J. Pharm. Tech. Res.</source><year>2015</year><volume>8</volume><fpage>60</fpage><lpage>68</lpage></element-citation></ref><ref id="B113-ijms-21-07078"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azam</surname><given-names>M.A.</given-names></name><name><surname>Suresh</surname><given-names>B.</given-names></name></person-group><article-title>Biological activities of 2-mercaptobenzothiazole derivatives: A review</article-title><source>Sci. Pharm.</source><year>2012</year><volume>80</volume><fpage>789</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.3797/scipharm.1204-27</pub-id><?supplied-pmid 23264933?><pub-id pub-id-type="pmid">23264933</pub-id></element-citation></ref><ref id="B114-ijms-21-07078"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokwani</surname><given-names>P.</given-names></name><name><surname>Nagori</surname><given-names>B.P.</given-names></name><name><surname>Batra</surname><given-names>N.</given-names></name><name><surname>Goyal</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group><article-title>Benzoxazole: The molecule of diverse biological activities</article-title><source>J. Chem. Pharm. Res.</source><year>2011</year><volume>3</volume><fpage>302</fpage><lpage>311</lpage></element-citation></ref><ref id="B115-ijms-21-07078"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Semenova</surname><given-names>M.D.</given-names></name><name><surname>Shtro</surname><given-names>A.A.</given-names></name><name><surname>Orshanskaya</surname><given-names>I.R.</given-names></name><name><surname>Zarubaev</surname><given-names>V.V.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus</article-title><source>Med. Chem. Commun.</source><year>2017</year><volume>8</volume><fpage>960</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1039/c6md00657d</pub-id></element-citation></ref><ref id="B116-ijms-21-07078"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borisova</surname><given-names>M.S.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Semenova</surname><given-names>M.D.</given-names></name><name><surname>Tolstikova</surname><given-names>T.G.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title>Antiulcerogenic activity of borneol derivatives</article-title><source>Russ. Chem. Bull.</source><year>2018</year><volume>67</volume><fpage>558</fpage><lpage>561</lpage></element-citation></ref><ref id="B117-ijms-21-07078"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kononova</surname><given-names>A.A.</given-names></name><name><surname>Sokolova</surname><given-names>A.S.</given-names></name><name><surname>Cheresiz</surname><given-names>S.V.</given-names></name><name><surname>Yarovaya</surname><given-names>O.I.</given-names></name><name><surname>Nikitina</surname><given-names>R.A.</given-names></name><name><surname>Chepurnov</surname><given-names>A.A.</given-names></name><name><surname>Pokrovskya</surname><given-names>A.G.</given-names></name><name><surname>Salakhutdinov</surname><given-names>N.F.</given-names></name></person-group><article-title><italic>N</italic>-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry</article-title><source>Med. Chem. Commun.</source><year>2017</year><volume>8</volume><fpage>2233</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.1039/c7md00424a</pub-id></element-citation></ref><ref id="B118-ijms-21-07078"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Farhan</surname><given-names>K.A.</given-names></name><name><surname>Warad</surname><given-names>I.</given-names></name><name><surname>Al-Resayes</surname><given-names>S.I.</given-names></name><name><surname>Fouda</surname><given-names>M.M.</given-names></name><name><surname>Ghazzali</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis, structural chemistry and antimicrobial activity of (&#x02013;)-borneol derivative</article-title><source>Cent. Eur. J. Chem.</source><year>2010</year><volume>8</volume><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.2478/s11532-010-1093-0</pub-id></element-citation></ref><ref id="B119-ijms-21-07078"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Luan</surname><given-names>D.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Antibacterial adhesion of borneol-based polymer via surface chiral stereochemistry</article-title><source>ACS Appl. Mater. Interfaces</source><year>2014</year><volume>6</volume><fpage>19371</fpage><lpage>19377</lpage><pub-id pub-id-type="doi">10.1021/am505481q</pub-id><pub-id pub-id-type="pmid">25331199</pub-id></element-citation></ref><ref id="B120-ijms-21-07078"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Antibacterial adhesion of poly(methyl methacrylate) modified by borneol acrylate</article-title><source>ACS Appl. Mater. Interfaces</source><year>2016</year><volume>8</volume><fpage>28522</fpage><lpage>28528</lpage><pub-id pub-id-type="doi">10.1021/acsami.6b10498</pub-id><pub-id pub-id-type="pmid">27712052</pub-id></element-citation></ref><ref id="B121-ijms-21-07078"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorman</surname><given-names>H.J.D.</given-names></name><name><surname>Deans</surname><given-names>S.G.</given-names></name></person-group><article-title>Antimicrobial agents from plants: Antibacterial activity of plant volatile oils</article-title><source>J. Appl. Microbiol.</source><year>2000</year><volume>88</volume><fpage>308</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2000.00969.x</pub-id><pub-id pub-id-type="pmid">10736000</pub-id></element-citation></ref><ref id="B122-ijms-21-07078"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>L.M.</given-names></name><name><surname>Lin</surname><given-names>C.Y.</given-names></name><name><surname>Chen</surname><given-names>C.Y.</given-names></name><name><surname>Tsai</surname><given-names>Y.C.</given-names></name></person-group><article-title>Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin<sup>&#x000ae;</sup>, on the healing of skin wound</article-title><source>Biomaterials</source><year>2003</year><volume>24</volume><fpage>3005</fpage><lpage>3012</lpage><pub-id pub-id-type="doi">10.1016/S0142-9612(03)00126-1</pub-id><pub-id pub-id-type="pmid">12895572</pub-id></element-citation></ref><ref id="B123-ijms-21-07078"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Zwitterionic-based surface via the coelectrodeposition of colloid particles and tannic acid with bacterial resistance but cell adhesion properties</article-title><source>ACS Biomater. Sci. Eng.</source><year>2018</year><volume>4</volume><fpage>4122</fpage><lpage>4131</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.8b01239</pub-id></element-citation></ref><ref id="B124-ijms-21-07078"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Gan</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Borneol-modified chitosan: Antimicrobial adhesion properties and application in skin flora protection</article-title><source>Carbohydr. Polym.</source><year>2020</year><volume>228</volume><fpage>115378</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2019.115378</pub-id><?supplied-pmid 31635731?><pub-id pub-id-type="pmid">31635731</pub-id></element-citation></ref><ref id="B125-ijms-21-07078"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Quan</surname><given-names>K.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Antifungal graphene oxide-borneol composite</article-title><source>Colloids Surf. B Biointerfaces</source><year>2017</year><volume>160</volume><fpage>220</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2017.09.023</pub-id><?supplied-pmid 28942156?><pub-id pub-id-type="pmid">28942156</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-21-07078-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Division of monoterpenes (acyclic, monocyclic, bicyclic).</p></caption><graphic xlink:href="ijms-21-07078-g001"/></fig><fig id="ijms-21-07078-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The natural origin of monoterpenes and their biological applications.</p></caption><graphic xlink:href="ijms-21-07078-g002"/></fig><fig id="ijms-21-07078-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Ester derivatives of naturally occurring geraniol.</p></caption><graphic xlink:href="ijms-21-07078-g003"/></fig><fig id="ijms-21-07078-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Geraniol-based phenols/methoxyphenols.</p></caption><graphic xlink:href="ijms-21-07078-g004"/></fig><fig id="ijms-21-07078-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The isomers of 6,7-dihydroxy-3,7-dimethyloct-2-enoic acid derivatives of geraniol.</p></caption><graphic xlink:href="ijms-21-07078-g005"/></fig><fig id="ijms-21-07078-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Selected examples of geraniol-butanolide hybrid compounds.</p></caption><graphic xlink:href="ijms-21-07078-g006"/></fig><fig id="ijms-21-07078-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Representative thymol&#x02019;s derivatives with antimicrobial and antibacterial activities.</p></caption><graphic xlink:href="ijms-21-07078-g007"/></fig><fig id="ijms-21-07078-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Representative thymol derivatives with antibacterial activity.</p></caption><graphic xlink:href="ijms-21-07078-g008"/></fig><fig id="ijms-21-07078-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Selected aryl-azo-thymol derivatives with significant antibacterial and antifungal activities.</p></caption><graphic xlink:href="ijms-21-07078-g009"/></fig><fig id="ijms-21-07078-f010" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Selected thymol derivatives with significant antifungal activities.</p></caption><graphic xlink:href="ijms-21-07078-g010"/></fig><fig id="ijms-21-07078-f011" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Selected thymol derivatives with antioxidant activities.</p></caption><graphic xlink:href="ijms-21-07078-g011"/></fig><fig id="ijms-21-07078-f012" orientation="portrait" position="float"><label>Figure 12</label><caption><p>Thymol derivatives with anticancer activity.</p></caption><graphic xlink:href="ijms-21-07078-g012"/></fig><fig id="ijms-21-07078-f013" orientation="portrait" position="float"><label>Figure 13</label><caption><p>Thymol derivatives with anti-inflammatory activity.</p></caption><graphic xlink:href="ijms-21-07078-g013"/></fig><fig id="ijms-21-07078-f014" orientation="portrait" position="float"><label>Figure 14</label><caption><p>Thymol derivatives with inhibitory effects on some metabolic enzymes.</p></caption><graphic xlink:href="ijms-21-07078-g014"/></fig><fig id="ijms-21-07078-f015" orientation="portrait" position="float"><label>Figure 15</label><caption><p>Thymol derivatives with pharmacological activity.</p></caption><graphic xlink:href="ijms-21-07078-g015"/></fig><fig id="ijms-21-07078-f016" orientation="portrait" position="float"><label>Figure 16</label><caption><p>Selected myrtenal&#x02019;s derivatives with significant antifungal, herbicidal, antiviral, anticancer, and analgesic activities.</p></caption><graphic xlink:href="ijms-21-07078-g016"/></fig><fig id="ijms-21-07078-f017" orientation="portrait" position="float"><label>Figure 17</label><caption><p>Monoterpene-based 1,2,4- and 1,3,4-oxadiazole derivatives.</p></caption><graphic xlink:href="ijms-21-07078-g017"/></fig><fig id="ijms-21-07078-f018" orientation="portrait" position="float"><label>Figure 18</label><caption><p>Structural formulas of <italic>&#x003b1;</italic>-pinene and <italic>&#x003b2;</italic>-pinene enantiomers.</p></caption><graphic xlink:href="ijms-21-07078-g018"/></fig><fig id="ijms-21-07078-f019" orientation="portrait" position="float"><label>Figure 19</label><caption><p>(&#x02013;)-<italic>&#x003b2;</italic>-Pinene derivatives with antimicrobial and insecticidal activities.</p></caption><graphic xlink:href="ijms-21-07078-g019"/></fig><fig id="ijms-21-07078-f020" orientation="portrait" position="float"><label>Figure 20</label><caption><p>Representative pinene derivatives with pharmacological activity.</p></caption><graphic xlink:href="ijms-21-07078-g020"/></fig><fig id="ijms-21-07078-f021" orientation="portrait" position="float"><label>Figure 21</label><caption><p><italic>&#x003b1;</italic>-Pinene-based dithiadiazole compounds.</p></caption><graphic xlink:href="ijms-21-07078-g021"/></fig><fig id="ijms-21-07078-f022" orientation="portrait" position="float"><label>Figure 22</label><caption><p>The design strategy for (+)-camphor-based imines with effectiveness biological activity.</p></caption><graphic xlink:href="ijms-21-07078-g022"/></fig><fig id="ijms-21-07078-f023" orientation="portrait" position="float"><label>Figure 23</label><caption><p>Camphecene&#x02014;compound based on (+)-camphor and aminoethanol.</p></caption><graphic xlink:href="ijms-21-07078-g023"/></fig><fig id="ijms-21-07078-f024" orientation="portrait" position="float"><label>Figure 24</label><caption><p>Aliphatic (+)-camphor imines with various lengths of the aliphatic chain.</p></caption><graphic xlink:href="ijms-21-07078-g024"/></fig><fig id="ijms-21-07078-f025" orientation="portrait" position="float"><label>Figure 25</label><caption><p>Quaternary ammonium (+)-camphor derivatives.</p></caption><graphic xlink:href="ijms-21-07078-g025"/></fig><fig id="ijms-21-07078-f026" orientation="portrait" position="float"><label>Figure 26</label><caption><p>(+)-Camphor imine and hydrazone derivatives.</p></caption><graphic xlink:href="ijms-21-07078-g026"/></fig><fig id="ijms-21-07078-f027" orientation="portrait" position="float"><label>Figure 27</label><caption><p>(+)-Camphor <italic>N</italic>-acylhydrazones with various aliphatic, aromatic, and heterocyclic substituents.</p></caption><graphic xlink:href="ijms-21-07078-g027"/></fig><fig id="ijms-21-07078-f028" orientation="portrait" position="float"><label>Figure 28</label><caption><p><italic>&#x003b1;</italic>-Truxillic acid derivative with (+)-camphor fragment.</p></caption><graphic xlink:href="ijms-21-07078-g028"/></fig><fig id="ijms-21-07078-f029" orientation="portrait" position="float"><label>Figure 29</label><caption><p>(+)-Camphor amide derivatives with the heterocyclic fragment.</p></caption><graphic xlink:href="ijms-21-07078-g029"/></fig><fig id="ijms-21-07078-f030" orientation="portrait" position="float"><label>Figure 30</label><caption><p>(+)-Camphor based (&#x02013;)-cytisine with the heterocyclic fragment.</p></caption><graphic xlink:href="ijms-21-07078-g030"/></fig><fig id="ijms-21-07078-f031" orientation="portrait" position="float"><label>Figure 31</label><caption><p>Polycyclic nitrogen-containing heterocyclic compounds (<bold>121&#x02013;124</bold>) being (+)-camphoric acid (<bold>120</bold>) derivatives.</p></caption><graphic xlink:href="ijms-21-07078-g031"/></fig><fig id="ijms-21-07078-f032" orientation="portrait" position="float"><label>Figure 32</label><caption><p>Quaternary ammonium salts (<bold>126&#x02013;128</bold>) derived from (1<italic>S</italic>)-(+)-camphor-10-sulfonic acid (<bold>125</bold>).</p></caption><graphic xlink:href="ijms-21-07078-g032"/></fig><fig id="ijms-21-07078-f033" orientation="portrait" position="float"><label>Figure 33</label><caption><p>(1<italic>S</italic>)-(+)-Camphor-10-sulfonamide derivatives.</p></caption><graphic xlink:href="ijms-21-07078-g033"/></fig><fig id="ijms-21-07078-f034" orientation="portrait" position="float"><label>Figure 34</label><caption><p>Aliphatic and aromatic esters of (&#x02013;)-borneol derivatives were tested as antimicrobial agents [<xref rid="B109-ijms-21-07078" ref-type="bibr">109</xref>] and as antiproliferative and antioedematogenic agents [<xref rid="B108-ijms-21-07078" ref-type="bibr">108</xref>].</p></caption><graphic xlink:href="ijms-21-07078-g034a"/><graphic xlink:href="ijms-21-07078-g034b"/></fig><fig id="ijms-21-07078-f035" orientation="portrait" position="float"><label>Figure 35</label><caption><p><italic>&#x003b1;</italic>-Truxillic acid derivative with (&#x02013;)-borneol fragment.</p></caption><graphic xlink:href="ijms-21-07078-g035"/></fig><fig id="ijms-21-07078-f036" orientation="portrait" position="float"><label>Figure 36</label><caption><p>Ester derivative of natural occurring (&#x02013;)-borneol with hydrazinylidene group.</p></caption><graphic xlink:href="ijms-21-07078-g036"/></fig><fig id="ijms-21-07078-f037" orientation="portrait" position="float"><label>Figure 37</label><caption><p>The design strategy for heterocyclic (&#x02013;)-borneol-based esters with the effectiveness of the biological activity.</p></caption><graphic xlink:href="ijms-21-07078-g037"/></fig><fig id="ijms-21-07078-f038" orientation="portrait" position="float"><label>Figure 38</label><caption><p>(&#x02013;)-Borneol ester derivatives with different <italic>N</italic>- and <italic>S</italic>-nucleophiles.</p></caption><graphic xlink:href="ijms-21-07078-g038"/></fig><fig id="ijms-21-07078-f039" orientation="portrait" position="float"><label>Figure 39</label><caption><p>(&#x02013;)-Borneol and (&#x02013;)-isoborneol derivatives with morpholine fragment.</p></caption><graphic xlink:href="ijms-21-07078-g039"/></fig><fig id="ijms-21-07078-f040" orientation="portrait" position="float"><label>Figure 40</label><caption><p><italic>N</italic>-Heterocyclic esters of (&#x02013;)-borneol derivatives as antiulcerogenic agents.</p></caption><graphic xlink:href="ijms-21-07078-g040"/></fig><fig id="ijms-21-07078-f041" orientation="portrait" position="float"><label>Figure 41</label><caption><p><italic>N</italic>-Heterocyclic esters of (&#x02013;)-borneol derivatives as vaccinia virus inhibitors.</p></caption><graphic xlink:href="ijms-21-07078-g041"/></fig><fig id="ijms-21-07078-f042" orientation="portrait" position="float"><label>Figure 42</label><caption><p>(&#x02013;)-Borneol derivative, 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl methane sulfonate as antibacterial agent.</p></caption><graphic xlink:href="ijms-21-07078-g042"/></fig><fig id="ijms-21-07078-f043" orientation="portrait" position="float"><label>Figure 43</label><caption><p>Borneol-based polymer.</p></caption><graphic xlink:href="ijms-21-07078-g043"/></fig></floats-group></article>